SWI/SNF and the histone chaperone Rtt106 drive expression of the Pleiotropic Drug Resistance network genes
Open accessAbstract
The Pleiotropic Drug Resistance (PDR) network is central to the drug response in fungi, and its overactivation is associated with drug resistance. However, gene regulation of the PDR network is not well understood. Here, we show that the histone chaperone Rtt106 and the chromatin remodeller SWI/SNF control expression of the PDR network genes and confer drug resistance. In Saccharomyces cerevisiae , Rtt106 specifically localises to PDR network gene promoters dependent on transcription factor Pdr3, but not Pdr1, and is essential for Pdr3-mediated basal expression of the PDR network genes, while SWI/SNF is essential for both basal and drug-induced expression. Also in the pathogenic fungus Candida glabrata , Rtt106 and SWI/SNF regulate drug-induced PDR gene expression. Consistently, loss of Rtt106 or SWI/SNF sensitises drug-resistant S. cerevisiae mutants and C. glabrata to antifungal drugs. Since they cooperatively drive PDR network gene expression, Rtt106 and SWI/SNF represent potential therapeutic targets to combat antifungal resistance.
AI snapshot
Written from the paper’s full text.
TL;DR
Rtt106 and SWI/SNF are chromatin regulators that drive expression of the fungal Pleiotropic Drug Resistance (PDR) network and confer azole antifungal resistance. In *S. cerevisiae*, Rtt106 acts through Pdr3 for basal PDR gene expression, while SWI/SNF supports both basal and drug-induced expression; related roles are conserved in *C. glabrata*.
Key findings
- Rtt106 binds PDR network gene promoters, including *PDR5*, at PDRE sites; 19 of 20 promoters in cluster 1 belong to PDR network genes, and Rtt106 binding there depends on Pdr3 but not Pdr1.
- Loss of Rtt106 reduced mRNA levels of 16 of 20 Type A PDR network genes, with strong reductions in *PDR5*, *CIS1*, and *RSB1*; *pdr3Δ* showed similar reductions, while *pdr1Δ* did not.
- Pdr1, but neither Pdr3 nor Rtt106, was required for ketoconazole-induced transient expression of 22 PDR network genes increased more than 4-fold in WT.
- SWI/SNF was required for both basal and ketoconazole-induced PDR gene expression; *snf2Δ* reduced *PDR5* mRNA and was highly azole-sensitive. In *C. glabrata*, loss of CgRtt106 or CgSnf2 reduced ketoconazole-induced *CgCDR1*/*CgCDR2* expression and increased azole sensitivity.
Methods
- Used *S. cerevisiae* (S288C/BY4741 backgrounds) and *C. glabrata* (ATCC 2001), with ChIP-seq, ChIP-qPCR, RNA-seq, Northern blot, luciferase reporter, western blot, GST pull-down, spot assays, and SILAC-based minichromosome proteomics.
- ChIP-seq classified Rtt106 promoter binding into clusters/types based on WT binding and changes in *pdr1Δ pdr3Δ*, *hir1Δ*, and *yta7Δ*; RNA-seq differential expression used edgeR with FDR < 0.05, and GO analysis used GO Term Finder.
- Nucleosome and TBP analyses reused published MNase-seq, ChEC-seq, and TSS datasets; most ChIP-qPCR/RNA-seq experiments used three biological replicates, while minichromosome mass spectrometry was performed once.
Limitations
- The paper states that it remains unknown whether Rtt106-regulated basal *PDR5* expression directly leads to drug resistance, and whether Rtt106 affects drug-induced *PDR5* expression during long-term drug exposure.
- The authors could not test mitochondrial dysfunction-mediated drug resistance because the phenotype was not reproducibly observed in their strain background; how Rtt106 binds Pdr3 and how CgRtt106/CgSWI/SNF upregulate drug-induced expression also remain to be elucidated.
- Evident from the text: minichromosome mass spectrometry was n = 1, some validation experiments were n = 1 or representative repeats, and the study does not test clinical *C. glabrata* isolates or directly assay nucleosome turnover at *PDR5*.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 96 cited sources checked · 0 supported · 0 flagged
- Findingown data
No obvious correlation of genes whose expression increased in rtt106Δ and Rtt106 binding at those genes was observed.
“No obvious correlation of genes whose expression increased in rtt106Δ and Rtt106 binding at those genes was observed.”
Quote in the paperNot a substantial claim - Findingown data
All three types of Rtt106-bound promoters show atypically wide NDRs.
“We observed that all three types of Rtt106-bound promoters show atypically wide NDRs (Fig. 2g)”
Quote in the paperNot a substantial claim - Findingown data
Rtt106 peak summits coincide with the PDRE in promoters such as PDR5, PDR15, SNQ2 and SPO24.
“Furthermore, the Rtt106 peak summits coincided with the PDRE in such promoters e.g. PDR5, PDR15, SNQ2 and SPO24 (Fig. 2a, Rtt106 ChIP in WT).”
Quote in the paperSubstantial claim - Findingown data
Rtt106 binding to the PDRE-containing promoters is almost completely abolished in the absence of both Pdr1 and Pdr3.
“Rtt106 binding to the PDRE-containing promoters was almost completely abolished in the absence of both Pdr1 and Pdr3 (Fig. 2a, Rtt106 ChIP in pdr1Δ pdr3Δ)”
Quote in the paperSubstantial claim - Findingown data
No common feature was found in the Type C promoter regions.
“No common feature was found in these promoter regions.”
Quote in the paperNot a substantial claim
- Findingown data
The effect of Rtt106 loss on mRNA levels of the genes classified in Type C was not uniform.
“The effect of Rtt106 loss on mRNA levels of the genes classified in Type C was not uniform.”
Quote in the paperNot a substantial claim - Findingown data
5 out of the top 10 Rtt106-binding promoters contain at least one PDRE.
“Interestingly, 5 out of the top 10 Rtt106-binding promoters contain at least one PDRE (Fig. 1c).”
Quote in the paperSubstantial claim - Findingown data
Many Rtt106-bound promoters (61 out of 79 gene promoters) show regulated expression, either in response to environmental changes or during the cell cycle.
“Many Rtt106-bound promoters (61 out of 79 gene promoters) show regulated expression, either in response to environmental changes or during the cell cycle (Supplementary Data 2).”
Quote in the paperSubstantial claim - Findingown data
mRNA levels of 10 out of 50 Type C genes were significantly reduced, including the uridine permease FUI1 and the copper transporter CTR1.
“mRNA levels of some of those genes (10 out of 50 genes) were significantly reduced, including the uridine permease FUI1 and the copper transporter CTR1 (Fig. 3a and Supplementary Data 3).”
Quote in the paperNot a substantial claim - Findingreasoning
Rtt106 binding to the HTA1-HTB1 promoter is not affected by the loss of Pdr1 and Pdr3.
“Rtt106 binding to the HTA1-HTB1 promoter was not affected by the loss of Pdr1 and Pdr3, as expected since the HTA1-HTB1 promoter does not contain a PDRE (Fig. 2b, Rtt106 ChIP in pdr1Δ pdr3Δ).”
Quote in the paperNot a substantial claim - Findingown data
Rtt106-binding promoters cluster into 9 groups based on Rtt106 binding in WT and the effects of pdr1Δ pdr3Δ, hir1Δ and yta7Δ mutations.
“Rtt106-binding promoters clustered into 9 groups (clusters 1–9) based on Rtt106 binding in WT and the effects of pdr1Δ pdr3Δ, hir1Δ and yta7Δ mutations (Fig. 2c, d and Supplementary Data 1).”
Quote in the paperSubstantial claim - Findingown data
Not all PDRE-containing promoters are bound by Rtt106.
“Note that not all PDRE-containing promoters were bound by Rtt106 (Supplementary Fig. 1a).”
Quote in the paperNot a substantial claim - Findingown data
Yta7 limits Rtt106 binding at the PDRE-containing promoters.
“We further observed that Yta7, a boundary protein that restricts Rtt106 binding at the histone promoters31,32 (Fig. 2b, yta7Δ), limits Rtt106 binding also at the PDRE-containing promoters, as loss of Yta7 increased Rtt106 binding (Fig. 2a, yta7Δ).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [31] Fillingham, J. et al. Two-color cell array screen reveals interdependent roles for histone chaperones and a chromatin boundary regulator in histone gene repression. Mol. Cell 35, 340–351 (2009). source
Not checked in the free run.
- cites [32] Zunder, R. M. & Rine, J. Direct interplay among histones, histone chaperones, and a chromatin boundary protein in the control of histone gene expression. Mol. Cell Biol. 32, 4337–4349 (2012). source
Not checked in the free run.
- Findingown data
19 out of 20 promoters in cluster 1 belong to PDR network genes.
“Interestingly, 19 out of 20 promoters in cluster 1 belong to PDR network genes (Fig. 2c–f)”
Quote in the paperSubstantial claim - Findingcitation
At the histone promoters, RTT106 deletion causes further reduction of nucleosome occupancy.
“At the histone promoters, RTT106 deletion causes further reduction of nucleosome occupancy as reported previously31 (Fig. 2g, Type B, compare green dashed line with solid line).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [31] Fillingham, J. et al. Two-color cell array screen reveals interdependent roles for histone chaperones and a chromatin boundary regulator in histone gene repression. Mol. Cell 35, 340–351 (2009). source
Not checked in the free run.
- Findingown data
Deletion of PDR3 in the rtt106Δ background had no additive effect on mRNA changes when compared to the single rtt106Δ mutant.
“Consistent with that notion, we further observed that deletion of PDR3 in the rtt106Δ background had no additive effect on mRNA changes when compared to the single rtt106Δ mutant (Fig. 3e and Supplementary Table 1).”
Quote in the paperSubstantial claim - Findingown data
The peak summit of Rtt106 binding to the PDR5 promoter is at its four PDREs.
“The peak summit of Rtt106 binding to the PDR5 promoter was observed at its four PDREs, which are recognised by transcription factors Pdr1 and Pdr3 (Fig. 1b).”
Quote in the paperSubstantial claim - Findingown data
mRNA levels of non-PDR genes that are decreased in rtt106Δ also tended to decrease in pdr3Δ.
“mRNA levels of non-PDR genes that are decreased in rtt106Δ also tended to decrease in pdr3Δ (Fig. 3c and Supplementary Data 3).”
Quote in the paperNot a substantial claim - Findingown data
Loss of Rtt106 causes an increase in mRNA levels for most genes that normally show low expression, including meiosis genes such as genes related to sporulation that are suppressed in vegetative growth.
“Remarkably, loss of Rtt106 caused an increase in mRNA levels for most genes that normally show low expression (Fig. 3a) including meiosis genes, for example, genes related to sporulation (Fig. 3b) that are suppressed in vegetative growth.”
Quote in the paperNot a substantial claim - Findingown data
Gene ontology analysis of the 50 genes with Type C promoters shows a significant enrichment of 'Cell Periphery' (p-value 0.00015; 19 of 50 genes).
“Gene ontology analysis of the 50 genes with these Type C promoters shows a significant enrichment of ‘Cell Periphery’ (p-value, 0.00015; 19 of 50 genes; Supplementary Fig. 1c).”
Quote in the paperNot a substantial claim - Findingown data
At the PDRE-containing (Type A) and Type C promoters, Rtt106 removal did not alter the NDR profile.
“Surprisingly, however, at the PDRE-containing (Type A) and the Type C promoters, Rtt106 removal did not alter the NDR profile”
Quote in the paperSubstantial claim - Findingown data
Rtt106 binds equally strongly at the promoter of the multidrug transporter gene PDR5.
“Strikingly, we observed equally strong Rtt106 binding at the promoter of the multidrug transporter gene PDR5 (Fig. 1b).”
Quote in the paperNot a substantial claim - Findingown data
The HIR histone chaperone contributes to Rtt106 recruitment to PDRE-containing promoters.
“We observed that the HIR histone chaperone, a crucial factor for recruitment of Rtt106 to the HTA1-HTB1 promoter31,32 (Fig. 2b, hir1Δ), contributes to Rtt106 recruitment to PDRE-containing promoters, since the loss of the HIR subunit Hir1 caused a reduction of Rtt106 binding (Fig. 2a, hir1Δ).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [31] Fillingham, J. et al. Two-color cell array screen reveals interdependent roles for histone chaperones and a chromatin boundary regulator in histone gene repression. Mol. Cell 35, 340–351 (2009). source
Not checked in the free run.
- cites [32] Zunder, R. M. & Rine, J. Direct interplay among histones, histone chaperones, and a chromatin boundary protein in the control of histone gene expression. Mol. Cell Biol. 32, 4337–4349 (2012). source
Not checked in the free run.
- Findingown data
SWI/SNF recruitment to the PDR5 promoter is dependent mainly on Pdr3.
“We further found that SWI/SNF recruitment to the PDR5 promoter is dependent mainly on Pdr3 (Fig. 5c, d).”
Quote in the paperSubstantial claim - Findingown data
Increase of nucleosome occupancy caused by loss of Snf2 in regions spanning −100 to 0 bp from the dyad of the +1 nucleosome is significantly higher at PDR network gene promoters bound by SWI/SNF and Rtt106 than at promoters not bound by SWI/SNF.
“We observed that increase of nucleosome occupancy caused by loss of Snf2 in those regions is significantly higher at the PDR network gene promoters bound by SWI/SNF and Rtt106 than at promoters not bound by SWI/SNF (Fig. 6f).”
Quote in the paperSubstantial claim - Findingown data
Rtt106 binds Pdr3 in vitro in yeast cell lysate, as shown by higher affinity for GST-Pdr3 than GST alone.
“We next tested the physical interaction of Rtt106 with Pdr3 by an in vitro GST pull-down analysis and observed that Rtt106 shows a higher affinity for GST-Pdr3 than GST alone, when testing cell lysate from the yeast with HA-tagged Rtt106 (Fig. 4e), suggesting that Rtt106 binds Pdr3 in this condition.”
Quote in the paperSubstantial claim - Findingown data
Ketoconazole treatment did not cause a significant increase in the recruitment of Rtt106 to the PDR5 promoter.
“Consistently, ketoconazole treatment did not cause a significant increase in the recruitment of Rtt106 to the PDR5 promoter (Supplementary Fig. 3e).”
Quote in the paperNot a substantial claim - Findingown data
Pdr3 protein level is reduced in snf2Δ compared to WT.
“As expected, the protein level of Pdr3 in snf2Δ is reduced, compared to WT (Supplementary Fig. 4e), consistent with the reduction of mRNA level of PDR3 in snf2Δ (Supplementary Table 2).”
Quote in the paperSubstantial claim - Findingown data
Fluconazole did not induce PDR5 expression.
“We used ketoconazole to test drug-induced expression since fluconazole did not induce PDR5 expression (Supplementary Fig. 2b).”
Quote in the paperSubstantial claim - Findingown data
Rtt106 and SWI/SNF do not always colocalise at promoters.
“Note though that Rtt106 and SWI/SNF do not always colocalise at promoters (Supplementary Fig. 7a), suggesting a specific requirement for their colocalisation at a subset of promoters.”
Quote in the paperSubstantial claim - Findingown data
Rtt106 and SWI/SNF factors also tended to colocalise at Type B promoters.
“Rtt106 and SWI/SNF factors also tended to colocalise at Type B promoters.”
Quote in the paperSubstantial claim - Findingown data
PDR5 mRNA is greatly decreased in the absence of Snf2 when grown in YPD.
“Our RNA-seq analysis showed that PDR5 mRNA was greatly decreased in the absence of Snf2, a catalytic subunit of SWI/SNF, when grown in YPD (Fig. 5h).”
Quote in the paperSubstantial claim - Findingown data
The contributions of Asf1 and Rtt109 to Rtt106 recruitment at PDR5 are less than at the HTA1-HTB1 histone promoter.
“We found that histone chaperone Asf1 and histone acetyltransferase Rtt109 (in addition to HIR and Yta7) also contribute to Rtt106 recruitment to the PDR5 promoter, although their contributions at PDR5 are less than at the HTA1-HTB1 histone promoter (Fig. 4f).”
Quote in the paperNot a substantial claim - Findingown data
A few peptides from Pdr1 were identified in the immunopurified fraction of SWI/SNF by mass spectrometry.
“Interestingly, a few peptides from Pdr1 were identified in the immunopurified fraction of SWI/SNF, by mass spectrometry (Supplementary Fig. 6c, highlighted in red), providing further supporting evidence for the interaction of SWI/SNF with Pdr1.”
Quote in the paperNot a substantial claim - Findingown data
No clear correlation between SWI/SNF and Rtt106 binding was observed for Type C genes.
“In contrast, no clear correlation between SWI/SNF and Rtt106 binding was observed for Type C genes (Fig. 6b, c).”
Quote in the paperNot a substantial claim - Findingcitation
Rtt106 and SWI/SNF physically interact.
“The possibility that Rtt106 and SWI/SNF cooperate is further supported by their physical interaction (Fig. 6d)33.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [33] Ferreira, M. E., Flaherty, K. & Prochasson, P. The Saccharomyces cerevisiae histone chaperone Rtt106 Mediates the cell cycle recruitment of SWI/SNF and RSC to the HIR-dependent histone genes. PLoS ONE 6, e21113 (2011). source
Not checked in the free run.
- Findingown data
Pdr3 binding to the PDR5 promoter is reduced by ~50% in rtt106Δ compared to WT.
“However, we observed ~50% reduction of Pdr3 binding to the PDR5 promoter in rtt106Δ, compared to WT, possibly caused by the reduction of protein and mRNA levels of PDR3 in rtt106Δ (Supplementary Fig. 4d, e and Supplementary Data 3).”
Quote in the paperSubstantial claim - Findingown data
SWI/SNF recruitment to the PDR5 promoter increases in response to ketoconazole.
“Consistent with this idea, SWI/SNF recruitment to the PDR5 promoter increased in response to ketoconazole, which stimulates only Pdr1 in the condition tested (Fig. 5e).”
Quote in the paperSubstantial claim - Findingown data
PDR3 mRNA level is reduced in snf2Δ.
“As expected, the protein level of Pdr3 in snf2Δ is reduced, compared to WT (Supplementary Fig. 4e), consistent with the reduction of mRNA level of PDR3 in snf2Δ (Supplementary Table 2).”
Quote in the paperSubstantial claim - Findingown data
Changes in mRNA levels of genes in Type A in snf2Δ are similar to those in rtt106Δ.
“Consistently, changes in mRNA levels of genes in Type A in snf2Δ are similar to those in rtt106Δ (Fig. 6c and Supplementary Table 2).”
Quote in the paperSubstantial claim - Findingown data
The mRNA levels of 22 genes, all with PDRE in their promoters, were increased more than four-fold in response to ketoconazole in WT.
“The mRNA levels of 22 genes, all with PDRE in their promoters, were increased more than four-fold in response to ketoconazole in WT (Fig. 3f).”
Quote in the paperSubstantial claim - Findingcitation
In the absence of Snf2, the +1 nucleosome is shifted towards the TATA-box at the PDR5 promoter.
“We utilised the published datasets of nucleosome occupancy20 and TSS49 and observed that in the absence of Snf2 the +1 nucleosome is shifted towards the TATA-box at the PDR5 promoter (Fig. 6a, red rectangle).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [20] Kubik, S. et al. Opposing chromatin remodelers control transcription initiation frequency and start site selection. Nat. Struct. Mol. Biol. 26, 744–754 (2019). source
Not checked in the free run.
- cites [49] Malabat, C., Feuerbach, F., Ma, L., Saveanu, C. & Jacquier, A. Quality control of transcription start site selection by nonsense-mediated-mRNA decay. elife 4, e06722 (2015). source
Not checked in the free run.
- Findingown data
snf2Δ is highly sensitive to azole antifungals.
“Consistent with an essential role of Snf2 in upregulating PDR5 expression, snf2Δ is highly sensitive to azole antifungals (Fig. 5k and Supplementary Figs. 3f and 6d).”
Quote in the paperSubstantial claim - Findingown data
In the pathogenic fungus Candida glabrata, Rtt106 and SWI/SNF regulate drug-induced PDR gene expression.
“Also in the pathogenic fungus Candida glabrata, Rtt106 and SWI/SNF regulate drug-induced PDR gene expression.”
Quote in the paperSubstantial claim - Findingcitation
Loss of all other SWI/SNF subunits tested also sensitised S. cerevisiae to azole antifungals, except for snf11Δ and swp82Δ.
“Loss of all other SWI/SNF subunits tested also sensitised S. cerevisiae to azole antifungals, except for snf11Δ and swp82Δ in which PDR5 mRNA levels were not reduced44 (Fig. 5k and Supplementary Fig. 6d, e).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [44] Kemmeren, P. et al. Large-scale genetic perturbations reveal regulatory networks and an abundance of gene-specific repressors. Cell 157, 740–752 (2014). source
Not checked in the free run.
- Findingown data
No obvious change in nucleosome occupancy was observed at promoters not bound by SWI/SNF upon Snf2 loss.
“Snf2 loss had a similar effect at other PDR network gene promoters bound by both SWI/SNF and Rtt106 (Fig. 6e, compare dashed and solid magenta lines), while no obvious change was observed at promoters not bound by SWI/SNF (Fig. 6e, grey lines).”
Quote in the paperSubstantial claim - Findingown data
Snf2 contributes to ketoconazole-induced, transient expression of PDR network genes including PDR5.
“Interestingly, Snf2 also contributes to ketoconazole-induced, transient expression of PDR network genes including PDR5 (Fig. 5i, j).”
Quote in the paperSubstantial claim - Findingown data
Loss of Snf6 sensitised pdr3-GOF to ketoconazole.
“We further observed that loss of Snf6 (a fungal-specific subunit of SWI/SNF) reduced PDR5 mRNA in the hyperactive pdr3-GOF mutant (pdr3-2) and sensitised it to ketoconazole (Fig. 5l, m).”
Quote in the paperSubstantial claim - Findingown data
SWI/SNF binds strongly to 16 of the 20 Rtt106-bound promoters classified as Type A.
“SWI/SNF binds strongly to 16 of the 20 Rtt106-bound promoters classified as Type A (Fig. 6b and Supplementary Data 6), indicating that SWI/SNF colocalises with Rtt106 at the majority of the PDR network gene promoters, and suggesting that these two factors are likely to cooperatively regulate expression of the PDR network genes.”
Quote in the paperSubstantial claim - Findingown data
Loss of Snf6 did not reduce PDR5 mRNA in the hyperactive pdr1-GOF (pdr1-3) grown in YPD.
“Loss of Snf6 did not reduce PDR5 mRNA in the hyperactive pdr1-GOF (pdr1-3) grown in YPD, but combining pdr1-GOF and snf6Δ caused a major growth defect even in the absence of antifungal drugs (Fig. 5l, n) through an unknown mechanism.”
Quote in the paperNot a substantial claim - Findingown data
Asf1 and Rtt109, in addition to HIR and Yta7, contribute to Rtt106 recruitment to the PDR5 promoter.
“We found that histone chaperone Asf1 and histone acetyltransferase Rtt109 (in addition to HIR and Yta7) also contribute to Rtt106 recruitment to the PDR5 promoter, although their contributions at PDR5 are less than at the HTA1-HTB1 histone promoter (Fig. 4f).”
Quote in the paperSubstantial claim - Findingown data
Snf2 loss had a similar effect at other PDR network gene promoters bound by both SWI/SNF and Rtt106.
“Snf2 loss had a similar effect at other PDR network gene promoters bound by both SWI/SNF and Rtt106 (Fig. 6e, compare dashed and solid magenta lines), while no obvious change was observed at promoters not bound by SWI/SNF (Fig. 6e, grey lines).”
Quote in the paperSubstantial claim - Findingown data
The azole antifungals tested did not induce PDR5 expression in YPD.
“YPD was not used for these induction experiments since the azole antifungals tested did not induce PDR5 expression in YPD (Supplementary Fig. 2c).”
Quote in the paperSubstantial claim - Findingown data
Loss of RTT106 sensitised S. cerevisiae to azole antifungal drugs, to an extent similar to pdr3Δ.
“Consistently, loss of RTT106 sensitised S. cerevisiae to azole antifungal drugs, to an extent similar to pdr3Δ (Fig. 4c and Supplementary Fig. 3f).”
Quote in the paperSubstantial claim - Findingown data
Recombinant His-Rtt106 purified from E. coli was not co-precipitated with GST-Pdr3.
“However, His-Rtt106 purified from E. coli expression system was not co-precipitated with GST-Pdr3 (Supplementary Fig. 4f), implying there may be another molecular requirement for binding, or possibly that recombinant Rtt106 is not properly folded to bind Pdr3 in the condition tested.”
Quote in the paperNot a substantial claim - Findingown data
Combining pdr1-GOF and snf6Δ caused a major growth defect even in the absence of antifungal drugs.
“Loss of Snf6 did not reduce PDR5 mRNA in the hyperactive pdr1-GOF (pdr1-3) grown in YPD, but combining pdr1-GOF and snf6Δ caused a major growth defect even in the absence of antifungal drugs (Fig. 5l, n) through an unknown mechanism.”
Quote in the paperNot a substantial claim - Findingown data
Loss of Snf6 reduced PDR5 mRNA in the hyperactive pdr3-GOF mutant (pdr3-2).
“We further observed that loss of Snf6 (a fungal-specific subunit of SWI/SNF) reduced PDR5 mRNA in the hyperactive pdr3-GOF mutant (pdr3-2) and sensitised it to ketoconazole (Fig. 5l, m).”
Quote in the paperSubstantial claim - Findingreasoning
Loss of Rtt106 or SWI/SNF sensitises drug-resistant S. cerevisiae mutants and C. glabrata to antifungal drugs.
“Consistently, loss of Rtt106 or SWI/SNF sensitises drug-resistant S. cerevisiae mutants and C. glabrata to antifungal drugs.”
Quote in the paperSubstantial claim - Findingown data
Pdr3 binding to the PDR5 promoter is reduced in snf2Δ compared to WT.
“Concomitantly, Pdr3 binding to the PDR5 promoter is reduced in snf2Δ, compared to WT (Supplementary Fig. 4d).”
Quote in the paperSubstantial claim - Findingown data
No obvious contribution of CgRtt106 nor CgSWI/SNF to the basal expression of the PDR network genes in C. glabrata was detected.
“We detected no obvious contribution of CgRtt106 nor CgSWI/SNF to the basal expression of the PDR network genes in C. glabrata, which might reflect the fact that without drugs PDR gene expression is very low, compared to expression upon ketoconazole treatment (Fig. 7a, YPD vs YEP + ketoconazole).”
Quote in the paperSubstantial claim - Findingown data
In YPD without antifungal drugs, loss of CgRtt106 or CgSnf2 did not consistently reduce mRNA of the PDR network genes.
“In contrast, in YPD without antifungal drugs, loss of CgRtt106 or CgSnf2 did not consistently reduce mRNA of the PDR network genes (Fig. 7a and Supplementary Fig. 8b).”
Quote in the paperSubstantial claim - Findingcitation
Loss of Rtt106 does not change the steady-state level of nucleosomes at the PDR5 promoter.
“In contrast, loss of Rtt106 does not change the steady-state level of nucleosomes at the PDR5 promoter (Supplementary Fig. 7c)29, leaving the possibility that at the PDR5 promoter Rtt106 may regulate nucleosome turnover, an effect not observable by MNase-seq nucleosome mapping.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [29] Lombardi, L. M., Davis, M. D. & Rine, J. Maintenance of nucleosomal balance in cis by conserved AAA-ATPase Yta7. Genetics 199, 105–116 (2015). source
Not checked in the free run.
- Findingcitation
In the absence of Rtt106, nucleosome positioning at the PDR5 promoter was not obviously changed.
“However, while the +1 nucleosome at the PDR5 promoter was shifted in the snf2 mutant, in the absence of Rtt106 nucleosome positioning was not obviously changed29 (Supplementary Fig. 7c), suggesting that the effect of Rtt106 on PDR5 transcription is not directly mediated through the SWI/SNF effect on nucleosome position.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [29] Lombardi, L. M., Davis, M. D. & Rine, J. Maintenance of nucleosomal balance in cis by conserved AAA-ATPase Yta7. Genetics 199, 105–116 (2015). source
Not checked in the free run.
- Findingown data
Loss of CgRtt106 causes reduced induction of mRNA of CgCDR1, CgCDR2 and other PDR network genes in cells transiently treated with ketoconazole.
“Interestingly, loss of CgRtt106 (CAGL0H08041g) caused reduced induction of mRNA of the multidrug transporter genes CgCDR1, CgCDR2 and of other PDR network genes, in cells transiently treated with ketoconazole (Fig. 7a orange bars and Supplementary Fig. 8a).”
Quote in the paperSubstantial claim - Findingown data
The binding of SWI/SNF to the PDR5 promoter was confirmed by ChIP-qPCR analysis with three biological replicates with similar results.
“The binding of SWI/SNF to the PDR5 promoter (found by the minichromosome isolation experiment) was subsequently confirmed by ChIP-qPCR analysis with three biological replicates with similar results.”
Quote in the paperSubstantial claim - Findingown data
Yeast Rtt106 is enriched at wider nucleosome-free regions upstream of TSSs.
“Interestingly, at promoters, human HIRA and ASF1a essentially localise to nucleosome-free TSSs52, reminiscent of our findings that yeast Rtt106 is enriched at wider nucleosome-free regions upstream of TSSs (Fig. 2g).”
Quote in the paperNot a substantial claim - Findingown data
TBP binding to the PDR network gene promoters is significantly reduced in the absence of Snf2, compared to promoters not bound by SWI/SNF.
“Consistent with this idea, the binding of the TATA-box-binding protein TBP to the PDR network gene promoters is significantly reduced in the absence of Snf2, compared to that of promoters not bound by SWI/SNF (Fig. 6g and Supplementary Fig. 7b).”
Quote in the paperSubstantial claim - Findingown data
CgRtt106 and CgSWI/SNF bind at least two sites within the CgCDR1 promoter.
“We next tested if CgRtt106 and CgSWI/SNF localise at the CgCDR1 promoter (which contains multiple PDRE and PDRE-like sequences; Fig. 7b), and found they bind at least two sites within the CgCDR1 promoter (Fig. 7c, d, proximal and distal).”
Quote in the paperSubstantial claim - Findingown data
Ketoconazole treatment did not increase CgRtt106 or CgSWI/SNF binding to the CgCDR1 promoter.
“Ketoconazole treatment did not increase CgRtt106 or CgSWI/SNF binding to the CgCDR1 promoter (Fig. 7c, d), suggesting that these factors are already bound to the CgCDR1 promoter before induction of its expression by the drug.”
Quote in the paperNot a substantial claim - Findingown data
An even more striking reduction of induction of those mRNAs is observed in the absence of CgSnf2.
“An even more striking reduction was observed in the absence of SWI/SNF subunit CgSnf2 (Fig. 7a grey bars and Supplementary Fig. 8a).”
Quote in the paperSubstantial claim - Premisecitation
Drug resistance to azole antifungals in clinical isolates of C. glabrata is almost exclusively associated with overexpression of multidrug transporter genes CgCDR1 (homolog of ScPDR5) and CgCDR2.
“Drug resistance to azole antifungals in clinical isolates of C. glabrata is almost exclusively associated with overexpression of multidrug transporter genes CgCDR1 (homolog of ScPDR5) and CgCDR29.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [9] Ferrari, S. et al. Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence. PLoS Pathog. 5, e1000268 (2009). source
Not checked in the free run.
- Interpretationown data
Recruitment of Rtt106 to the PDRE-containing promoters depends on Pdr1 or Pdr3 or both.
“indicating that recruitment of Rtt106 to the PDRE-containing promoters depends on Pdr1 or Pdr3 or both.”
Quote in the paperSubstantial claim - Interpretationown data
Rtt106 may generally bind a subset of gene promoters where expression is induced by specific cellular or environmental circumstances, such as PDR network genes, histone genes and other transporter genes.
“We surmise that Rtt106 may generally bind a subset of gene promoters where expression is induced by specific cellular or environmental circumstances—such as PDR network genes, histone genes and other transporter genes.”
Quote in the paperNot a substantial claim - Interpretationown data
At Type A and Type C promoters, the histone chaperone activity of Rtt106 does not affect nucleosome positioning and occupancy at least under the tested conditions.
“suggesting that at these promoters the histone chaperone activity of Rtt106 does not affect nucleosome positioning and occupancy at least under the tested conditions (Fig. 2g, compare rtt106Δ with WT).”
Quote in the paperSubstantial claim - Interpretationreasoning
Yta7 may limit Rtt106 binding through different mechanisms at the PDRE-containing and histone promoter sites.
“Yta7 may therefore limit Rtt106 binding through different mechanisms at the PDRE-containing and histone promoter sites.”
Quote in the paperSubstantial claim - Interpretationcitation
An increase in mRNA levels of 'Transposition' genes such as retrotransposons is probably linked to the effect of Rtt106 as a Regulator of Ty1 Transposition (RTT).
“An increase in mRNA levels of ‘Transposition’ genes such as retrotransposons (Fig. 3b) is probably linked to the effect of Rtt106 as a Regulator of Ty1 Transposition (RTT)43, the phenotype for which Rtt106 was originally identified.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [43] Scholes, D. T., Banerjee, M., Bowen, B. & Curcio, M. J. Multiple regulators of Ty1 transposition in Saccharomyces cerevisiae have conserved roles in genome maintenance. Genetics 159, 1449–1465 (2001). source
Not checked in the free run.
- Interpretationown data
Pdr3-mediated transcription of the PDR network genes is almost completely dependent on Rtt106.
“These results suggest that Pdr3-mediated transcription of the PDR network genes is almost completely dependent on Rtt106.”
Quote in the paperSubstantial claim - Interpretationown data
Rtt106 binds the regions containing PDRE in promoters of the PDR network genes.
“These results suggest that Rtt106 binds the regions containing PDRE in promoters of the PDR network genes.”
Quote in the paperSubstantial claim - Interpretationown data
Rtt106 may be recruited to the AGP1 and ECL1 promoters through a mechanism similar to that at histone promoters.
“indicating that Rtt106 may be recruited to the AGP1 and ECL1 promoter through the mechanism similar to that at histone promoters.”
Quote in the paperSubstantial claim - Interpretationown data
Pdr3, not Pdr1, is the main transcription factor responsible for the expression of the PDR network genes at basal levels.
“These results suggest that Pdr3, not Pdr1, is the main transcription factor responsible for the expression of the PDR network genes at basal levels”
Quote in the paperSubstantial claim - Interpretationown data
Rtt106 acts with Pdr3 in basal expression of the PDR network genes.
“and that Rtt106 acts with Pdr3 in these conditions.”
Quote in the paperSubstantial claim - Interpretationown data
The effect on low-expression genes in rtt106Δ is due to a general histone occupancy defect occurring independently of Pdr3.
“consistent with the effect on these genes in rtt106Δ being due to a general histone occupancy defect, occurring independently of Pdr3.”
Quote in the paperSubstantial claim - Interpretationown data
The effect of Rtt106 loss on PDR5 expression is not simply caused indirectly by global change in chromatin structure due to loss of Rtt106.
“These selective effects on pdr3-GOF also suggest that the effect of Rtt106 loss on PDR5 expression is not simply caused indirectly by global change in chromatin structure due to loss of Rtt106.”
Quote in the paperSubstantial claim - Interpretationown data
Pdr1 might contribute to the recruitment of SWI/SNF to the PDR5 promoter.
“Pdr1 might contribute to the recruitment of SWI/SNF to the PDR5 promoter since residual binding of SWI/SNF was observed in the single pdr3Δ mutant, compared to the double pdr1Δ pdr3Δ mutant (Fig. 5c, d).”
Quote in the paperSubstantial claim- Rests on an assumption: Ketoconazole stimulates only Pdr1 in the condition tested.
- Interpretationown data
Rtt106 is critical to mediate hyperactivation of Pdr3.
“Rtt106 is therefore critical to mediate hyperactivation of Pdr3.”
Quote in the paperSubstantial claim - Interpretationreasoning
Ume6 likely binds to the DNA sequence 5′-TTGCCGCCGA-3′ located 580 bp upstream of the PDR5 ATG.
“Ume6 likely binds to the DNA sequence 5′-TTGCCGCCGA-3′ located 580 bp upstream of the PDR5 ATG, which is similar to the Ume6 recognition sequence 5′-TAGCCGCCGA-3′.”
Quote in the paperNot a substantial claim - Interpretationown data
SWI/SNF regulates the position of the TSS-associated +1 nucleosome at promoters of the PDR network genes.
“These results suggest that SWI/SNF regulates the position of the TSS-associated +1 nucleosome at promoters of the PDR network genes.”
Quote in the paperSubstantial claim - Interpretationreasoning
SWI/SNF represents a potential therapeutic target to combat antifungal resistance.
“Taken together, these results suggest that SWI/SNF is an essential factor mediating resistance to azole antifungals through upregulating PDR5 expression, and therefore represents a potential therapeutic target to combat antifungal resistance.”
Quote in the paperSubstantial claim - Interpretationown data
SWI/SNF is an essential factor mediating resistance to azole antifungals through upregulating PDR5 expression.
“Taken together, these results suggest that SWI/SNF is an essential factor mediating resistance to azole antifungals through upregulating PDR5 expression, and therefore represents a potential therapeutic target to combat antifungal resistance.”
Quote in the paperSubstantial claim - Interpretationown data
Rtt106 regulates the expression of PDR3, one of the PDRE-containing genes.
“While not ruling out some direct contribution of Rtt106 to Pdr3 recruitment, these results suggest clearly that Rtt106 regulates the expression of PDR3, one of the PDRE-containing genes.”
Quote in the paperSubstantial claim - Interpretationown data
SWI/SNF colocalises with Rtt106 at the majority of the PDR network gene promoters.
“SWI/SNF binds strongly to 16 of the 20 Rtt106-bound promoters classified as Type A (Fig. 6b and Supplementary Data 6), indicating that SWI/SNF colocalises with Rtt106 at the majority of the PDR network gene promoters, and suggesting that these two factors are likely to cooperatively regulate expression of the PDR network genes.”
Quote in the paperSubstantial claim - Interpretationown data
Rtt106 and SWI/SNF are likely to cooperatively regulate expression of the PDR network genes.
“SWI/SNF binds strongly to 16 of the 20 Rtt106-bound promoters classified as Type A (Fig. 6b and Supplementary Data 6), indicating that SWI/SNF colocalises with Rtt106 at the majority of the PDR network gene promoters, and suggesting that these two factors are likely to cooperatively regulate expression of the PDR network genes.”
Quote in the paperSubstantial claim - Interpretationreasoning
Rtt106 and SWI/SNF cooperatively drive PDR network gene expression.
“Since they cooperatively drive PDR network gene expression, Rtt106 and SWI/SNF represent potential therapeutic targets to combat antifungal resistance.”
Quote in the paperSubstantial claim - Interpretationown data
Pdr3 recruits Rtt106 to the PDR5 promoter to upregulate its transcription.
“These results suggest that Pdr3 recruits Rtt106 to the PDR5 promoter to upregulate its transcription.”
Quote in the paperSubstantial claim - Interpretationcitation
Histone chaperones have a conserved role at promoters in yeast and human.
“These findings suggest that histone chaperones have a conserved role at promoters in yeast and human.”
Quote in the paperNot a substantial claim - Interpretationreasoning
SWI/SNF directs the position of the +1 nucleosome at the PDR5 promoter to activate its transcription.
“These results are consistent with a role for SWI/SNF in directing the position of the +1 nucleosome at the PDR5 promoter to activate its transcription.”
Quote in the paperSubstantial claim- Rests on an assumption: The TSS-associated +1 nucleosome is critical for transcription initiation.
- Interpretationnone given
In S. cerevisiae, Rtt106 is recruited to the promoter of PDR5 exclusively through the transcription factor Pdr3.
“In S. cerevisiae, Rtt106 is recruited to the promoter of the multidrug transporter gene PDR5 exclusively through the transcription factor Pdr3, which drives Pdr3-mediated expression of PDR5, and confers resistance to azole antifungals.”
Quote in the paperNot a substantial claim - Interpretationown data
In response to ketoconazole, SWI/SNF mediates Pdr1-dependent drug-induced expression of the PDR network genes in S. cerevisiae.
“Taken together, we propose that during logarithmic growth Rtt106 and SWI/SNF bind to promoters of the PDR network genes mainly through Pdr3, and cooperatively drive Pdr3-dependent expression; while in response to ketoconazole SWI/SNF mediates Pdr1-dependent-drug-induced expression of the PDR network genes in S. cerevisiae (Fig. 6h).”
Quote in the paperSubstantial claim - Interpretationreasoning
Changes in nucleosome occupancy and position caused by loss of Snf2 likely reduce the accessibility of the TATA-box and therefore reduce its transcription.
“The changes in nucleosome occupancy and position caused by the loss of Snf2 likely reduce the accessibility of the TATA-box and therefore reduce its transcription (Fig. 6a lower cartoons).”
Quote in the paperSubstantial claim- Rests on an assumption: The TSS-associated +1 nucleosome is critical for transcription initiation.
- Interpretationown data
CgRtt106 and CgSWI/SNF are already bound to the CgCDR1 promoter before induction of its expression by the drug.
“Ketoconazole treatment did not increase CgRtt106 or CgSWI/SNF binding to the CgCDR1 promoter (Fig. 7c, d), suggesting that these factors are already bound to the CgCDR1 promoter before induction of its expression by the drug.”
Quote in the paperSubstantial claim - Premisecitation
A small molecule inhibitor disrupting the interaction between CgPdr1 and CgMediator has already been successfully used to re-sensitise drug-resistant clinical isolates to azole antifungals.
“In this context, a small molecule inhibitor disrupting the interaction between CgPdr1 and CgMediator has already been successfully used to re-sensitise drug-resistant clinical isolates to azole antifungals58.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [58] Nishikawa, J. L. et al. Inhibiting fungal multidrug resistance by disrupting an activator-mediator interaction. Nature 530, 485–489 (2016). source
Not checked in the free run.
- Interpretationreasoning
CgRtt106 and CgSWI/SNF are potential therapeutic targets to combat antifungal resistance of C. glabrata.
“CgRtt106 and CgSWI/SNF are therefore potential therapeutic targets to combat antifungal resistance of C. glabrata.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Rtt106 regulates turnover of the nucleosomes surrounding the NDR at the PDR5 promoter, to enable transient TATA-box region exposure allowing transcriptional regulators to access their binding sites.
“We instead favour a model where Rtt106 regulates ‘turnover’ of the nucleosomes surrounding the NDR at the PDR5 promoter, to enable transient TATA-box region exposure allowing transcriptional regulators to access their binding sites.”
Quote in the paperSubstantial claim - Interpretationcitation
SWI/SNF regulates the expression of PDR5 by shifting the TSS-associated +1 nucleosome.
“Our results and a published report20 suggest that SWI/SNF regulates the expression of PDR5 by shifting the TSS-associated +1 nucleosome, which is critical for transcription initiation.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [20] Kubik, S. et al. Opposing chromatin remodelers control transcription initiation frequency and start site selection. Nat. Struct. Mol. Biol. 26, 744–754 (2019). source
Not checked in the free run.
- Rests on an assumption: The TSS-associated +1 nucleosome is critical for transcription initiation.
- Interpretationcitation
The effect of Rtt106 on PDR5 transcription is not directly mediated through the SWI/SNF effect on nucleosome position.
“However, while the +1 nucleosome at the PDR5 promoter was shifted in the snf2 mutant, in the absence of Rtt106 nucleosome positioning was not obviously changed29 (Supplementary Fig. 7c), suggesting that the effect of Rtt106 on PDR5 transcription is not directly mediated through the SWI/SNF effect on nucleosome position.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [29] Lombardi, L. M., Davis, M. D. & Rine, J. Maintenance of nucleosomal balance in cis by conserved AAA-ATPase Yta7. Genetics 199, 105–116 (2015). source
Not checked in the free run.
- Classified as probably not a substantial claim. 53
- May combine two claims. 64
Probably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationRtt106 localises at the promoter of the histone gene pair HTA1-HTB1 in S. cerevisiae.
“As expected31,32, Rtt106 localised at the promoter of the histone gene pair HTA1-HTB1 (Fig. 1a).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [31] Fillingham, J. et al. Two-color cell array screen reveals interdependent roles for histone chaperones and a chromatin boundary regulator in histone gene repression. Mol. Cell 35, 340–351 (2009). source
Not checked in the free run.
- cites [32] Zunder, R. M. & Rine, J. Direct interplay among histones, histone chaperones, and a chromatin boundary protein in the control of histone gene expression. Mol. Cell Biol. 32, 4337–4349 (2012). source
Not checked in the free run.
May combine two claims.
Findingown dataType C promoters contain some non-PDR transporter genes (FUI1, CTR1, FTR1, PMA1, PHO87 and PUT4) but do not include any PDR genes.
“This third type contains some non-PDR transporter genes, e.g. FUI1, CTR1, FTR1, PMA1, PHO87 and PUT4, but does not include any PDR genes.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn our experiments, only HHF1 mRNA was significantly increased in rtt106Δ, unlike previous reports which found additional histone genes affected.
“Regarding histone gene expression, in our experiments only HHF1 mRNA was significantly increased in rtt106Δ (Fig. 3a and Supplementary Data 3), unlike previous reports which found additional histone genes affected31,32.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [31] Fillingham, J. et al. Two-color cell array screen reveals interdependent roles for histone chaperones and a chromatin boundary regulator in histone gene repression. Mol. Cell 35, 340–351 (2009). source
Not checked in the free run.
- cites [32] Zunder, R. M. & Rine, J. Direct interplay among histones, histone chaperones, and a chromatin boundary protein in the control of histone gene expression. Mol. Cell Biol. 32, 4337–4349 (2012). source
Not checked in the free run.
May combine two claims.
Findingown dataLoss of Rtt106 causes a significant reduction of mRNA levels of the majority of the PDR network genes whose promoters it binds (16 out of 20 genes in Type A), with a particular reduction in PDR5, CIS1 and RSB1 expression.
“Loss of Rtt106 caused a significant reduction of mRNA levels of the majority of the PDR network genes whose promoters it binds (16 out of 20 genes in Type A), with a particular reduction in PDR5, CIS1 and RSB1 expression (Fig. 3a and Supplementary Fig. 2a and Supplementary Data 3).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe yta7Δ mutation does not cause Rtt106 binding to spread from PDRE-containing promoters, unlike at the histone promoters where Rtt106 spreads into regions normally occupied by Yta7.
“However, the yta7Δ mutation did not cause Rtt106 binding to spread from PDRE-containing promoters, unlike at the histone promoters where Rtt106 was observed to spread into regions normally occupied by Yta7 (Fig. 2a, b, compare our Rtt106 ChIP data with the published Yta7 ChIP data shown at bottom29).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [29] Lombardi, L. M., Davis, M. D. & Rine, J. Maintenance of nucleosomal balance in cis by conserved AAA-ATPase Yta7. Genetics 199, 105–116 (2015). source
Not checked in the free run.
May combine two claims.
Findingown dataIn clusters 7 and 8, Rtt106 shows clear peaks that do not depend on Pdr1, Pdr3 or HIR, and are not limited by loss of Yta7.
“In clusters 7 and 8, we found another type of Rtt106-binding promoters, where Rtt106 shows clear peaks (rather than broader signals) that do not depend on Pdr1, Pdr3 or HIR, and are not limited by the loss of Yta7 (Fig. 2e, ‘peaks’ in clusters 7 and 8, and Supplementary Fig. 1b and Supplementary Data 1).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataRtt106 is also enriched at centromeres, tRNA, snoRNA, and gene bodies of highly expressed genes, mainly found in clusters 7-9.
“Rtt106 was also enriched at centromeres, tRNA, snoRNA, and gene bodies of highly expressed genes, mainly found in clusters 7–9 (Fig. 2e and Supplementary Fig. 1d and Supplementary Data 1).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAlmost all PDR network genes whose mRNA levels were reduced in rtt106Δ showed a similar reduction in pdr3Δ; however, no reduction was observed in the mRNA for most such genes in pdr1Δ.
“Almost all PDR network genes whose mRNA levels were reduced in rtt106Δ showed a similar reduction in pdr3Δ; however, no reduction was observed in the mRNA for most such genes in pdr1Δ (Fig. 3c, d and Supplementary Data 3).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataGene ontology analysis of downregulated genes in rtt106Δ shows significant enrichment of 'Transmembrane transport' genes, and 8 out of the 20 most reduced mRNAs correspond to transporter genes.
“Gene ontology analysis of the downregulated genes in rtt106Δ show significant enrichment of ‘Transmembrane transport’ genes (Fig. 3b), and 8 out of the 20 most reduced mRNA in rtt106Δ correspond to transporter genes (Supplementary Fig. 2a).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCluster 2 includes all histone gene pairs except HTA2-HTB2, as well as AGP1 and ECL1.
“This cluster included all histone gene pairs (except HTA2-HTB2 where Rtt106 does not bind strongly), as well as AGP1 and ECL1 (Fig. 2b, e, f)”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataNeither pdr1Δ nor pdr3Δ mutations caused increased mRNA from genes with low expression levels.
“As expected, neither pdr1Δ nor pdr3Δ mutations caused increased mRNA from genes with low expression levels (‘+’ symbols in Fig. 3c, d), consistent with the effect on these genes in rtt106Δ being due to a general histone occupancy defect, occurring independently of Pdr3.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCluster 2 contains promoters bound by Rtt106 dependent on HIR and limited by Yta7, but not dependent on Pdr1/3.
“Cluster 2 contains promoters bound by Rtt106 dependent on HIR and limited by Yta7, but not dependent on Pdr1/3.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataBoth Pdr1 and Pdr3 bind purified SWI/SNF in GST pull-down analyses.
“Furthermore, GST pull-down analyses showed that both Pdr1 and Pdr3 bind purified SWI/SNF (Fig. 5f, g and Supplementary Fig. 6b).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe SWI/SNF ATP-dependent chromatin-remodelling complex and the transcriptional regulatory protein Ume6 are enriched on the PDR5 promoter.
“Interestingly, we identified the SWI/SNF ATP-dependent chromatin-remodelling complex and the transcriptional regulatory protein Ume6 (Fig. 5b and Supplementary Data 5) as enriched on the PDR5 promoter.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataRtt106 is enriched on the PDR5 promoter by western blot, although it was not identified by mass spectrometry.
“Rtt106 enrichment on the PDR5 promoter was confirmed by western blot analysis, although it was not identified by mass spectrometry (Supplementary Fig. 6a).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataDeletion of PDR3 caused almost complete loss of Rtt106 recruitment to the PDR5 promoter, while deletion of PDR1 increased recruitment of Rtt106 to the PDR5 promoter.
“Strikingly, deletion of PDR3 caused almost complete loss of Rtt106 recruitment to the PDR5 promoter, while deletion of PDR1 actually increased recruitment of Rtt106 to the PDR5 promoter (Fig. 4d).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataLoss of Rtt106 sensitises pdr3-GOF but not pdr1-GOF to ketoconazole.
“Consistently, loss of Rtt106 sensitised pdr3-GOF, but not pdr1-GOF, to ketoconazole (Fig. 4h).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPDR1 is essential for the ketoconazole-induced, transient expression of these 22 genes, but neither PDR3 nor RTT106 is required.
“We found that PDR1 is essential for the ketoconazole-induced, transient expression of these 22 genes, but neither PDR3 nor RTT106 is required (Fig. 3f).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataRtt106 is not essential for Pdr3 recruitment to the PDR5 promoter; Pdr3 is still recruited there in the absence of Rtt106.
“Conversely, Rtt106 is not essential for Pdr3 recruitment to the PDR5 promoter, as Pdr3 is still recruited there in the absence of Rtt106, as shown by ChIP-qPCR using a tagged PDR3-13Myc strain confirmed as retaining protein function (Supplementary Fig. 4a–d).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown datapdr3Δ and rtt106Δ are sensitive to high doses of ketoconazole, while pdr1Δ is sensitive only to low doses but not to high doses.
“We further observed that pdr3Δ and rtt106Δ are sensitive to high doses of ketoconazole, while pdr1Δ is sensitive only to low doses but not to high doses (Supplementary Fig. 3f).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataSWI/SNF is essential for both basal and drug-induced expression of the PDR network genes.
“while SWI/SNF is essential for both basal and drug-induced expression.”
- Also stated in: § Introduction · boosted
“We further show that SWI/SNF acts as an essential activator of the PDR network genes for both basal and azole-induced expression, and therefore is essential for drug resistance of wild-type S. cerevisiae, and of a pdr3-GOF mutant.”
Quote in the paperSubstantial claim- Also stated in: § Introduction · boosted
May combine two claims.
Findingown dataNorthern blot analyses confirmed that Rtt106 acts with Pdr3 to mediate basal expression of PDR5, but Rtt106 is not essential for Pdr1-mediated transient expression of PDR5 in response to ketoconazole.
“In addition to RNA-seq (Fig. 3), Northern blot analyses confirmed that Rtt106 acts with Pdr3 to mediate basal expression of PDR5, but Rtt106 is not essential for Pdr1-mediated transient expression of PDR5 in response to ketoconazole (Supplementary Fig. 3a–d).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataLoss of Rtt106 reduces PDR5 mRNA in a pdr3-GOF (pdr3-2) mutant but not in a pdr1-GOF (pdr1-3) mutant.
“As expected, loss of Rtt106 caused the reduction of PDR5 mRNA in a pdr3-GOF (pdr3-2) mutant, but not in a pdr1-GOF (pdr1-3) mutant (Fig. 4g).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataRtt106 is required for activating the PDR5 promoter and for maintaining Pdr5 protein levels under non-drug-treated conditions.
“We further found using a luciferase expression assay that Rtt106 is required for activating the PDR5 promoter (Fig. 4a), and therefore for maintaining Pdr5 protein levels under non-drug-treated conditions (western blot analysis; Fig. 4b).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe minichromosome isolation/SILAC proteomics approach identified PDR5 promoter-binding proteins including Pdr1, Pdr3, and the RNA polymerase II Mediator complex, validating the approach.
“We successfully identified PDR5 promoter-binding proteins including transcription factors Pdr1 and Pdr3, and the RNA polymerase II Mediator complex that binds Pdr1 and Pdr37,47, validating this approach for capturing promoter-binding proteins in a near-native context (Fig. 5b and Supplementary Data 5).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [7] Thakur, J. K. et al. A nuclear receptor-like pathway regulating multidrug resistance in fungi. Nature 452, 604–609 (2008). source
Not checked in the free run.
- cites [47] Shahi, P., Gulshan, K., Näär, A. M. & Moye-Rowley, W. S. Differential roles of transcriptional mediator subunits in regulation of multidrug resistance gene expression in Saccharomyces cerevisiae. Mol. Biol. Cell 21, 2469–2482 (2010). source
Not checked in the free run.
May combine two claims.
Findingown dataCgsnf2Δ and, to a lesser extent, Cgrtt106Δ exhibit increased sensitivity to ketoconazole and fluconazole, along with a hyper-sensitive Cgcdr1Δ.
“We finally observed that along with a hyper-sensitive Cgcdr1Δ, Cgsnf2Δ and, to a lesser extent, Cgrtt106Δ exhibited increased sensitivity to ketoconazole and fluconazole (Fig. 7e).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataSequencing confirmed that pdr1-3 contains mutations Q411K, F815S, T820A, T921I and loss of 5Ns at 1011 aa, and pdr3-2 contains Q56R, H110Q, G834S, A885T, N916S and E941G.
“Sequencing of the inserted pdr1-3 and pdr3-2 genes in the S288C backgrounds confirmed that pdr1-3 contains the following mutations compared to the S288C reference genome: Q411K, F815S, T820A, T921I and loss of 5Ns at 1011 aa, while pdr3-2 contains Q56R, H110Q, G834S, A885T, N916S and E941G.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataCgRtt106 and CgSWI/SNF also localise at the CgCDR1 promoter in YPD.
“CgRtt106 and CgSWI/SNF also localise at the CgCDR1 promoter in YPD (Supplementary Fig. 8c), with higher background binding of CgRtt106 to a control locus probably because of its function in DNA replication.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationThe Pleiotropic Drug Resistance (PDR) network is central to the drug response in fungi.
“The Pleiotropic Drug Resistance (PDR) network is central to the drug response in fungi, and its overactivation is associated with drug resistance.”
- Also stated in: § Introduction · plain
“the Pleiotropic Drug Resistance (PDR) network of fungi works as the first line of defence against a broad range of xenobiotics4,5, and is central to the fungal drug response6,7.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [4] Sipos, G. & Kuchler, K. Fungal ATP-binding cassette (ABC) transporters in drug resistance & detoxification. Curr. Drug Targets 7, 471–481 (2006). source
Not checked in the free run.
- cites [5] Balzi, E. & Goffeau, A. Yeast multidrug resistance: the PDR network. J. Bioenerg. Biomembr. 27, 71–76 (1995). source
Not checked in the free run.
- cites [6] Paul, S. & Moye-Rowley, W. S. Multidrug resistance in fungi: regulation of transporter-encoding gene expression. Front. Physiol. 5, 143 (2014). source
Not checked in the free run.
- cites [7] Thakur, J. K. et al. A nuclear receptor-like pathway regulating multidrug resistance in fungi. Nature 452, 604–609 (2008). source
Not checked in the free run.
- Also stated in: § Introduction · plain
Classified as probably not a substantial claim.
PremisecitationPdr5, a major ATP-binding cassette (ABC) multidrug transporter, is critical for drug resistance in Saccharomyces cerevisiae.
“Among the PDR network gene products, Pdr5, a major ATP-binding cassette (ABC) multidrug transporter, is critical for drug resistance in Saccharomyces cerevisiae8, a fungus closely related to the pathogenic fungus Candida glabrata.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8] Golin, J. & Ambudkar, S. V. The multidrug transporter Pdr5 on the 25th anniversary of its discovery: an important model for the study of asymmetric ABC transporters. Biochem. J. 467, 353–363 (2015). source
Not checked in the free run.
Classified as probably not a substantial claim.
Premisenone givenOveractivation of the PDR network is associated with drug resistance.
“The Pleiotropic Drug Resistance (PDR) network is central to the drug response in fungi, and its overactivation is associated with drug resistance.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationPdr5 overexpression is one of the main causes of drug resistance in S. cerevisiae.
“Pdr5 overexpression is one of the main causes of drug resistance in S. cerevisiae8.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8] Golin, J. & Ambudkar, S. V. The multidrug transporter Pdr5 on the 25th anniversary of its discovery: an important model for the study of asymmetric ABC transporters. Biochem. J. 467, 353–363 (2015). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPdr1 activates increased gene expression in response to direct binding to the azole antifungal ketoconazole.
“Pdr1 and Pdr3 together sustain basal gene expression, and Pdr1 activates increased gene expression in response to direct binding to the azole antifungal ketoconazole7.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7] Thakur, J. K. et al. A nuclear receptor-like pathway regulating multidrug resistance in fungi. Nature 452, 604–609 (2008). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe yeast SWI/SNF complex is an ATP-dependent chromatin-remodelling complex composed of 12 subunits, 5 of which are fungal-specific.
“The yeast SWI/SNF complex is an ATP-dependent chromatin-remodelling complex, and it is composed of 12 subunits, 5 of which are fungal-specific36.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [36] Wang, C. et al. Structure of the yeast Swi/Snf complex in a nucleosome free state. Nat. Commun. 11, 3398 (2020). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationLoss of Rtt106 causes aberrant 'cryptic' transcription initiation within gene bodies and compromised silencing at the mating loci and telomeres, likely due to defective nucleosome assembly.
“Loss of Rtt106 causes aberrant ‘cryptic’ transcription initiation within gene bodies26 and compromised silencing at the mating loci and telomeres27,28, likely due to defective nucleosome assembly26,27,29.”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [26] Imbeault, D., Gamar, L., Rufiange, A., Paquet, E. & Nourani, A. The Rtt106 histone chaperone is functionally linked to transcription elongation and is involved in the regulation of spurious transcription from cryptic promoters in yeast. J. Biol. Chem. 283, 27350–27354 (2008). source
Not checked in the free run.
- cites [27] Zunder, R. M., Antczak, A. J., Berger, J. M. & Rine, J. Two surfaces on the histone chaperone Rtt106 mediate histone binding, replication, and silencing. Proc. Natl Acad. Sci. USA 109, E144–E153 (2012). source
Not checked in the free run.
- cites [28] Huang, S. et al. Rtt106p is a histone chaperone involved in heterochromatin-mediated silencing. Proc. Natl Acad. Sci. USA 102, 13410–13415 (2005). source
Not checked in the free run.
- cites [29] Lombardi, L. M., Davis, M. D. & Rine, J. Maintenance of nucleosomal balance in cis by conserved AAA-ATPase Yta7. Genetics 199, 105–116 (2015). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIn the late G1 and early S phase, Rtt106 recruits SWI/SNF, which activates transcription of the histone genes by releasing HIR- and RSC-mediated repression.
“In contrast, in the late G1 and early S phase Rtt106 recruits SWI/SNF, another ATP-dependent chromatin-remodelling complex, which activates transcription of the histone genes by releasing HIR- and RSC-mediated repression33,34.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [33] Ferreira, M. E., Flaherty, K. & Prochasson, P. The Saccharomyces cerevisiae histone chaperone Rtt106 Mediates the cell cycle recruitment of SWI/SNF and RSC to the HIR-dependent histone genes. PLoS ONE 6, e21113 (2011). source
Not checked in the free run.
- cites [34] Dimova, D., Nackerdien, Z., Furgeson, S., Eguchi, S. & Osley, M. A. A role for transcriptional repressors in targeting the yeast Swi/Snf complex. Mol. Cell 4, 75–83 (1999). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationRecruitment of SWI/SNF to promoters can be mediated through sequence-specific transcription factors including Gcn4, Pho4, Swi5 and Hap4.
“Recruitment of SWI/SNF to promoters can be mediated through sequence-specific transcription factors including Gcn4, Pho4, Swi5 and Hap441,42.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [41] Yudkovsky, N., Logie, C., Hahn, S. & Peterson, C. L. Recruitment of the SWI/SNF chromatin remodeling complex by transcriptional activators. Genes Dev. 13, 2369–2374 (1999). source
Not checked in the free run.
- cites [42] Neely, K. E., Hassan, A. H., Brown, C. E., Howe, L. & Workman, J. L. Transcription activator interactions with multiple SWI/SNF subunits. Mol. Cell Biol. 22, 1615–1625 (2002). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPdr1 and Pdr3 together sustain basal gene expression.
“Pdr1 and Pdr3 together sustain basal gene expression, and Pdr1 activates increased gene expression in response to direct binding to the azole antifungal ketoconazole7.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7] Thakur, J. K. et al. A nuclear receptor-like pathway regulating multidrug resistance in fungi. Nature 452, 604–609 (2008). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationRtt106, a fungal-specific histone chaperone, functions in histone deposition during DNA replication and transcription elongation in S. cerevisiae, and preferentially binds H3K56-acetylated histone H3-H4.
“Rtt106, a fungal-specific histone chaperone, functions in histone deposition during DNA replication and transcription elongation in S. cerevisiae, and preferentially binds H3K56-acetylated histone H3-H424–26.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [24] Su, D. et al. Structural basis for recognition of H3K56-acetylated histone H3-H4 by the chaperone Rtt106. Nature 483, 104–107 (2012). source
Not checked in the free run.
- cites [25] Li, Q. et al. Acetylation of histone H3 lysine 56 regulates replication-coupled nucleosome assembly. Cell 134, 244–255 (2008). source
Not checked in the free run.
- cites [26] Imbeault, D., Gamar, L., Rufiange, A., Paquet, E. & Nourani, A. The Rtt106 histone chaperone is functionally linked to transcription elongation and is involved in the regulation of spurious transcription from cryptic promoters in yeast. J. Biol. Chem. 283, 27350–27354 (2008). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationHyperactivation of Pdr1 or Pdr3 can be caused by gain-of-function (GOF) mutations in PDR1 or PDR3.
“Such hyperactivation can be caused by gain-of-function (GOF) mutations in PDR1 or PDR314,15 or mitochondrial dysfunction (e.g. loss of the mitochondrial genome), the latter of which only stimulates Pdr3-dependent gene expression16.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [14] Meyers, S. et al. Interaction of the yeast pleiotropic drug resistance genes PDR1 and PDR5. Curr. Genet. 21, 431–436 (1992). source
Not checked in the free run.
- cites [15] Wolfger, H., Mahe, Y., Parle-McDermott, A., Delahodde, A. & Kuchler, K. The yeast ATP binding cassette (ABC) protein genes PDR10 and PDR15 are novel targets for the Pdr1 and Pdr3 transcriptional regulators. FEBS Lett. 418, 269–274 (1997). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOutside S phase, Rtt106 forms a repressive complex together with other histone chaperones HIR and Asf1 to recruit RSC to the histone promoters.
“Outside S phase, Rtt106 forms a repressive complex together with other histone chaperones HIR and Asf1 to recruit RSC (Remodel the Structure of Chromatin), an essential ATP-dependent chromatin-remodelling complex, to the histone promoters31–33.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [31] Fillingham, J. et al. Two-color cell array screen reveals interdependent roles for histone chaperones and a chromatin boundary regulator in histone gene repression. Mol. Cell 35, 340–351 (2009). source
Not checked in the free run.
- cites [32] Zunder, R. M. & Rine, J. Direct interplay among histones, histone chaperones, and a chromatin boundary protein in the control of histone gene expression. Mol. Cell Biol. 32, 4337–4349 (2012). source
Not checked in the free run.
- cites [33] Ferreira, M. E., Flaherty, K. & Prochasson, P. The Saccharomyces cerevisiae histone chaperone Rtt106 Mediates the cell cycle recruitment of SWI/SNF and RSC to the HIR-dependent histone genes. PLoS ONE 6, e21113 (2011). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMitochondrial dysfunction (e.g. loss of the mitochondrial genome) only stimulates Pdr3-dependent gene expression.
“Such hyperactivation can be caused by gain-of-function (GOF) mutations in PDR1 or PDR314,15 or mitochondrial dysfunction (e.g. loss of the mitochondrial genome), the latter of which only stimulates Pdr3-dependent gene expression16.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [16] Hallstrom, T. C. & Moye-Rowley, W. S. Multiple signals from dysfunctional mitochondria activate the pleiotropic drug resistance pathway in Saccharomyces cerevisiae. J. Biol. Chem. 275, 37347–37356 (2000). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationExpression of PDR5 and the other PDR network genes in S. cerevisiae is regulated by Pdr1 and Pdr3, key transcription factors whose functions are partially redundant.
“The expression of PDR5 and the other PDR network genes in S. cerevisiae is regulated by Pdr1 and Pdr3, key transcription factors whose functions are partially redundant10–12.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [10] Balzi, E., Wang, M., Leterme, S., Van Dyck, L. & Goffeau, A. PDR5, a novel yeast multidrug resistance conferring transporter controlled by the transcription regulator PDR1. J. Biol. Chem. 269, 2206–2214 (1994). source
Not checked in the free run.
- cites [11] Katzmann, D. J., Burnett, P. E., Golin, J., Mahe, Y. & Moye-Rowley, W. S. Transcriptional control of the yeast PDR5 gene by the PDR3 gene product. Mol. Cell Biol. 14, 4653–4661 (1994).
Not checked in the free run.
- cites [12] Mahe, Y. et al. The ATP-binding cassette multidrug transporter Snq2 of Saccharomyces cerevisiae: a novel target for the transcription factors Pdr1 and Pdr3. Mol. Microbiol. 20, 109–117 (1996). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSWI/SNF localises to nucleosome-depleted regions (NDRs) in promoters and regulates the position of the transcription start site (TSS)-associated (or '+1') nucleosome critical for transcription initiation.
“SWI/SNF localises to nucleosome-depleted regions (NDRs) in promoters and regulates the position of the transcription start site (TSS)-associated (or ‘+1’) nucleosome critical for transcription initiation20.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [20] Kubik, S. et al. Opposing chromatin remodelers control transcription initiation frequency and start site selection. Nat. Struct. Mol. Biol. 26, 744–754 (2019). source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationHistone chaperones and ATP-dependent chromatin-remodelling complexes are important for gene regulation because they regulate nucleosome dynamics at promoters, restricting or increasing promoter accessibility for recruitment of transcription factors and RNA polymerase II (Pol II).
“Histone chaperones and ATP-dependent chromatin-remodelling complexes are accordingly important for gene regulation given they regulate nucleosome dynamics at promoters, restricting or increasing promoter accessibility for recruitment of transcription factors and RNA polymerase II (Pol II)19–23.”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [19] Kubik, S. et al. Sequence-directed action of RSC remodeler and general regulatory factors modulates +1 nucleosome position to facilitate transcription. Mol. Cell 71, 89–102 e105 (2018). source
Not checked in the free run.
- cites [20] Kubik, S. et al. Opposing chromatin remodelers control transcription initiation frequency and start site selection. Nat. Struct. Mol. Biol. 26, 744–754 (2019). source
Not checked in the free run.
- cites [21] Rufiange, A., Jacques, P. E., Bhat, W., Robert, F. & Nourani, A. Genome-wide replication-independent histone H3 exchange occurs predominantly at promoters and implicates H3 K56 acetylation and Asf1. Mol. Cell 27, 393–405 (2007). source
Not checked in the free run.
- cites [22] Adkins, M. W., Howar, S. R. & Tyler, J. K. Chromatin disassembly mediated by the histone chaperone Asf1 is essential for transcriptional activation of the yeast PHO5 and PHO8 genes. Mol. Cell 14, 657–666 (2004). source
Not checked in the free run.
- cites [23] Korber, P. et al. The histone chaperone Asf1 increases the rate of histone eviction at the yeast PHO5 and PHO8 promoters. J. Biol. Chem. 281, 5539–5545 (2006). source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationRecruitment of transcription machinery to promoters is restricted by nucleosomes.
“Recruitment of transcription machinery to promoters is restricted by nucleosomes19.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [19] Kubik, S. et al. Sequence-directed action of RSC remodeler and general regulatory factors modulates +1 nucleosome position to facilitate transcription. Mol. Cell 71, 89–102 e105 (2018). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationRtt106 localises at the promoters of three out of four histone gene pairs (HTA1-HTB1, HHT1-HHF1 and HHT2-HHF2, but not HTA2-HTB2) and restricts their transcription to S phase.
“Rtt106 localises at the promoters of three out of four histone gene pairs (HTA1-HTB1, HHT1-HHF1 and HHT2-HHF2, but not HTA2-HTB2), and restricts their transcription to S phase, when new histone supply is required to package newly synthesised DNA31,32.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [31] Fillingham, J. et al. Two-color cell array screen reveals interdependent roles for histone chaperones and a chromatin boundary regulator in histone gene repression. Mol. Cell 35, 340–351 (2009). source
Not checked in the free run.
- cites [32] Zunder, R. M. & Rine, J. Direct interplay among histones, histone chaperones, and a chromatin boundary protein in the control of histone gene expression. Mol. Cell Biol. 32, 4337–4349 (2012). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationRtt106 regulates the activity of the histone gene promoters during the cell cycle in S. cerevisiae.
“Apart from its role in histone deposition during replication and transcription elongation, Rtt106 regulates the activity of the histone gene promoters during the cell cycle in S. cerevisiae30.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [30] Eriksson, P. R., Ganguli, D., Nagarajavel, V. & Clark, D. J. Regulation of histone gene expression in budding yeast. Genetics 191, 7–20 (2012). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn C. glabrata, overexpression of drug transporter genes is caused by GOF mutations in the transcription factor Pdr1.
“In C. glabrata also, overexpression of the drug transporter genes is caused by GOF mutations in the transcription factor Pdr19.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] Ferrari, S. et al. Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence. PLoS Pathog. 5, e1000268 (2009). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSWI/SNF modulates nucleosome position to regulate the expression of a subset of genes including stress-responsive genes.
“SWI/SNF modulates nucleosome position to regulate the expression of a subset of genes including stress-responsive genes20,37–40.”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [20] Kubik, S. et al. Opposing chromatin remodelers control transcription initiation frequency and start site selection. Nat. Struct. Mol. Biol. 26, 744–754 (2019). source
Not checked in the free run.
- cites [37] Sudarsanam, P., Iyer, V. R., Brown, P. O. & Winston, F. Whole-genome expression analysis of snf/swi mutants of Saccharomyces cerevisiae. Proc. Natl Acad. Sci. USA 97, 3364–3369 (2000). source
Not checked in the free run.
- cites [38] Shivaswamy, S. & Iyer, V. R. Stress-dependent dynamics of global chromatin remodeling in yeast: dual role for SWI/SNF in the heat shock stress response. Mol. Cell Biol. 28, 2221–2234 (2008). source
Not checked in the free run.
- cites [39] Dutta, A. et al. Swi/Snf dynamics on stress-responsive genes is governed by competitive bromodomain interactions. Genes Dev. 28, 2314–2330 (2014). source
Not checked in the free run.
- cites [40] Gkikopoulos, T., Havas, K. M., Dewar, H. & Owen-Hughes, T. SWI/SNF and Asf1p cooperate to displace histones during induction of the saccharomyces cerevisiae HO promoter. Mol. Cell Biol. 29, 4057–4066 (2009). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationHyperactivation of Pdr1 or Pdr3 is the main cause of overexpression of PDR5 leading to drug resistance.
“Hyperactivation of Pdr1 or Pdr3 is the main cause of overexpression of PDR5 leading to drug resistance.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [14] Meyers, S. et al. Interaction of the yeast pleiotropic drug resistance genes PDR1 and PDR5. Curr. Genet. 21, 431–436 (1992). source
Not checked in the free run.
- cites [15] Wolfger, H., Mahe, Y., Parle-McDermott, A., Delahodde, A. & Kuchler, K. The yeast ATP binding cassette (ABC) protein genes PDR10 and PDR15 are novel targets for the Pdr1 and Pdr3 transcriptional regulators. FEBS Lett. 418, 269–274 (1997). source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationAccessibility of gene promoters is a key factor in gene regulation.
“Accessibility of gene promoters is a key factor in gene regulation17,18.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [17] Rhee, H. S. & Pugh, B. F. Genome-wide structure and organization of eukaryotic pre-initiation complexes. Nature 483, 295–301 (2012). source
Not checked in the free run.
- cites [18] Lai, W. K. M. & Pugh, B. F. Understanding nucleosome dynamics and their links to gene expression and DNA replication. Nat. Rev. Mol. Cell Biol. 18, 548–562 (2017). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPdr1 and Pdr3 recognise the PDR responsive element (PDRE: 5′-TCCG(C/T)GGA-3′) present in promoters of the PDR network genes through their Zn(2)-Cys(6) finger DNA-binding domains.
“Pdr1 and Pdr3 form a heterodimer or homodimers, which through their Zn(2)-Cys(6) finger DNA-binding domains13 recognise the PDR responsive element (PDRE: 5′-TCCG(C/T)GGA-3′) present in promoters of the PDR network genes.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] Mamnun, Y. M., Pandjaitan, R., Mahe, Y., Delahodde, A. & Kuchler, K. The yeast zinc finger regulators Pdr1p and Pdr3p control pleiotropic drug resistance (PDR) as homo- and heterodimers in vivo. Mol. Microbiol. 46, 1429–1440 (2002). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationRtt106 recruitment to the histone promoters almost completely depends on Asf1, HIR and acetylation of histone H3 at K56 (H3K56Ac), and is limited by Yta7.
“Rtt106 recruitment to the histone promoters almost completely depends on Asf1, HIR and acetylation of histone H3 at K56 (H3K56Ac), and is limited by Yta7, a bromodomain- and AAA-ATPase domain-containing boundary protein31,32,35.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [31] Fillingham, J. et al. Two-color cell array screen reveals interdependent roles for histone chaperones and a chromatin boundary regulator in histone gene repression. Mol. Cell 35, 340–351 (2009). source
Not checked in the free run.
- cites [32] Zunder, R. M. & Rine, J. Direct interplay among histones, histone chaperones, and a chromatin boundary protein in the control of histone gene expression. Mol. Cell Biol. 32, 4337–4349 (2012). source
Not checked in the free run.
- cites [35] Kurat, C. F. et al. Restriction of histone gene transcription to S phase by phosphorylation of a chromatin boundary protein. Genes Dev. 25, 2489–2501 (2011). source
Not checked in the free run.
May combine two claims.
Interpretationown dataRtt106 may be generally important for the expression of transporter genes, though some effects could be indirect.
“Rtt106 may therefore be generally important for the expression of transporter genes—even though we did not identify Rtt106 bound at all the gene promoters affected, suggesting some effects could be indirect.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationreasoningMildly deregulated transcription initiation occurs fairly ubiquitously in rtt106Δ, resulting in a readily apparent fold increase of mRNA with low abundance but a less obvious effect on mRNA with a high level of expression.
“We suspect that mildly deregulated transcription initiation occurs fairly ubiquitously in rtt106Δ, resulting in a readily apparent fold increase of mRNA with low abundance, but a less obvious effect on mRNA with a high level of expression.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningAtypically wide NDRs possibly reflect that inducible gene promoters are occupied by specific transcriptional regulators.
“possibly reflecting the fact that inducible gene promoters are occupied by specific transcriptional regulators.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationExpression of the PDR network genes can be induced by many substances, including the antifungal azole drug ketoconazole.
“Expression of the PDR network genes can be induced by many substances, including the antifungal azole drug ketoconazole7.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [7] Thakur, J. K. et al. A nuclear receptor-like pathway regulating multidrug resistance in fungi. Nature 452, 604–609 (2008). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThe decrease of non-PDR genes in pdr3Δ may represent an indirect consequence of PDR network gene dysregulation.
“We suspect that this may represent an indirect consequence of PDR network gene dysregulation, since it is unlikely that such genes are directly controlled by Pdr3.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataRtt106 generally upregulates the expression of the PDR network genes, in contrast to its repressive role in histone gene expression.
“These results suggest that Rtt106 generally upregulates the expression of the PDR network genes, in contrast to its repressive role in histone gene expression.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataHIR and Yta7 contribute to Rtt106 recruitment at the promoters of both the PDR network genes and the histone genes, but their specific effects differ somewhat in the two classes of promoters.
“Taken together, our results show that HIR and Yta7 contribute to Rtt106 recruitment at the promoters of both the PDR network genes and the histone genes, but their specific effects differ somewhat in the two classes of promoters.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationcitationThe increased mRNA in rtt106Δ may reflect increased transcription initiation caused by defective histone deposition or increased nucleosome spacing.
“This may reflect increased transcription initiation that could be caused by defective histone deposition or increased nucleosome spacing in rtt106Δ26,27,29.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [26] Imbeault, D., Gamar, L., Rufiange, A., Paquet, E. & Nourani, A. The Rtt106 histone chaperone is functionally linked to transcription elongation and is involved in the regulation of spurious transcription from cryptic promoters in yeast. J. Biol. Chem. 283, 27350–27354 (2008). source
Not checked in the free run.
- cites [27] Zunder, R. M., Antczak, A. J., Berger, J. M. & Rine, J. Two surfaces on the histone chaperone Rtt106 mediate histone binding, replication, and silencing. Proc. Natl Acad. Sci. USA 109, E144–E153 (2012). source
Not checked in the free run.
- cites [29] Lombardi, L. M., Davis, M. D. & Rine, J. Maintenance of nucleosomal balance in cis by conserved AAA-ATPase Yta7. Genetics 199, 105–116 (2015). source
Not checked in the free run.
May combine two claims.
Interpretationown dataRtt106 generally binds the promoters of the PDR network genes in a common manner designated Type A, fully dependent on Pdr1/3 and partially on HIR, and limited by Yta7.
“indicating that Rtt106 generally binds the promoters of the PDR network genes in a common manner that we designate ‘Type A’ i.e. fully dependent on Pdr1/3 and partially on HIR, and limited by Yta7.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationThe difference in histone gene effects may reflect the fact that we prepared RNA from asynchronous cells rather than cells at specific cell-cycle stages.
“This difference may reflect the fact that we prepared RNA from asynchronous cells rather than cells at specific cell-cycle stages31,32.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [31] Fillingham, J. et al. Two-color cell array screen reveals interdependent roles for histone chaperones and a chromatin boundary regulator in histone gene repression. Mol. Cell 35, 340–351 (2009). source
Not checked in the free run.
- cites [32] Zunder, R. M. & Rine, J. Direct interplay among histones, histone chaperones, and a chromatin boundary protein in the control of histone gene expression. Mol. Cell Biol. 32, 4337–4349 (2012). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAt the histone promoters, SWI/SNF is recruited by Rtt106, probably through direct physical interactions.
“However, at the histone promoters, SWI/SNF is recruited by Rtt106, probably through direct physical interactions33.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33] Ferreira, M. E., Flaherty, K. & Prochasson, P. The Saccharomyces cerevisiae histone chaperone Rtt106 Mediates the cell cycle recruitment of SWI/SNF and RSC to the HIR-dependent histone genes. PLoS ONE 6, e21113 (2011). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningIncreased recruitment of Rtt106 to the PDR5 promoter in pdr1Δ may reflect an increase of Pdr3 at the PDR5 promoter in the absence of Pdr1.
“Increased recruitment of Rtt106 to the PDR5 promoter in pdr1Δ may reflect an increase of Pdr3 at the PDR5 promoter in the absence of Pdr1.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningSWI/SNF regulates PDR5 expression by acting directly at the PDR5 promoter as well as through regulating gene expression of the transcription factor PDR3.
“Taken together, these results and the evidence of SWI/SNF binding to the PDR5 promoter suggest that SWI/SNF regulates PDR5 expression by acting directly at the PDR5 promoter as well as through regulating gene expression of the transcription factor PDR3.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataPdr3 and Rtt106 are more critical for resistance to continuous high doses of azole antifungals than Pdr1, and Pdr1 function alone cannot mediate resistance to high doses at the condition tested.
“This finding suggests that Pdr3 and Rtt106 are more critical for resistance to continuous high doses of azole antifungals than Pdr1; and that Pdr1 function alone cannot mediate resistance to high doses at the condition tested.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningRtt106 regulates PDR5 expression by acting directly at the PDR5 promoter, not only indirectly through regulating PDR3 expression.
“Our results nonetheless indicate that Rtt106 regulates PDR5 expression by acting directly at the PDR5 promoter (and not only indirectly through regulating PDR3 expression) as a ~50% reduction of Pdr3 binding at the PDR5 promoter in rtt106Δ cannot alone explain why rtt106Δ and pdr3Δ mutants have similar effects on PDR5 expression.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationcitationThe unexpected results might reflect that PDR3 undergoes auto-activation of its own transcription, while PDR1 does not.
“Although these are unexpected results since Pdr1 is critical for drug-induced expression of PDR5, this observation might reflect the fact that PDR3 undergoes auto-activation of its own transcription45, while PDR1 does not.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] Delahodde, A., Delaveau, T. & Jacq, C. Positive autoregulation of the yeast transcription factor Pdr3p, which is involved in control of drug resistance. Mol. Cell Biol. 15, 4043–4051 (1995). source
Not checked in the free run.
May combine two claims.
Interpretationown dataRtt106 recruitment to the PDR5 promoter depends on Pdr3, and not Pdr1.
“Rtt106 recruitment to the PDR5 promoter, therefore, depends on Pdr3, and not Pdr1.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataSWI/SNF is an essential upregulator of the PDR network genes both for basal and drug-induced expression.
“These results suggest that SWI/SNF is an essential upregulator of the PDR network genes both for basal and drug-induced expression.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataRtt106 regulates basal expression of PDR5 via Pdr3 and also mediates drug resistance.
“Overall, these results suggest that Rtt106 regulates basal expression of PDR5 via Pdr3 and also mediates drug resistance.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataRtt106 and Pdr3 are essential for basal expression of the PDR network genes during growth without antifungal agents, while Pdr1 mediates their azole-induced, transient expression.
“Overall, the results in Fig. 3 suggest that Rtt106 and Pdr3 are essential for basal expression of the PDR network genes during growth without antifungal agents, while Pdr1 mediates their azole-induced, transient expression.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationC. albicans Rtt106 and C. albicans SWI/SNF affect hyphae formation, which indirectly influences drug tolerance and pathogenicity.
“C. albicans Rtt106 and C. albicans SWI/SNF affect hyphae formation56,57, which indirectly influences drug tolerance and pathogenicity.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [56] Jenull, S. et al. The Candida albicans HIR histone chaperone regulates the yeast-to-hyphae transition by controlling the sensitivity to morphogenesis signals. Sci. Rep. 7, 8308 (2017). source
Not checked in the free run.
- cites [57] Mao, X., Cao, F., Nie, X., Liu, H. & Chen, J. The Swi/Snf chromatin remodeling complex is essential for hyphal development in Candida albicans. FEBS Lett. 580, 2615–2622 (2006). source
Not checked in the free run.
May combine two claims.
Interpretationown dataCgRtt106 and CgSWI/SNF are important for the expression of the PDR network genes in response to ketoconazole in C. glabrata, and therefore for its resistance to azole antifungals.
“Finally, we observed that CgRtt106 and CgSWI/SNF are important for the expression of the PDR network genes in response to ketoconazole in C. glabrata, and therefore for its resistance to azole antifungals, highlighting those factors as potential therapeutic targets to combat antifungal resistance of C. glabrata.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAt promoters, human HIRA and ASF1a essentially localise to nucleosome-free TSSs.
“Interestingly, at promoters, human HIRA and ASF1a essentially localise to nucleosome-free TSSs52, reminiscent of our findings that yeast Rtt106 is enriched at wider nucleosome-free regions upstream of TSSs (Fig. 2g).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [52] Pchelintsev, N. A. et al. Placing the HIRA histone chaperone complex in the chromatin landscape. Cell Rep. 3, 1012–1019 (2013). source
Not checked in the free run.
May combine two claims.
Interpretationown dataSWI/SNF plays a crucial role in both Pdr1- and Pdr3-mediated expression of the PDR network genes and confers azole drug resistance.
“Furthermore, we showed that SWI/SNF plays a crucial role in both Pdr1- and Pdr3-mediated expression of the PDR network genes and confers azole drug resistance.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataRtt106 and SWI/SNF are general regulators of the PDR network genes and confer drug resistance in S. cerevisiae, and their roles are largely conserved in the pathogenic fungus C. glabrata.
“Our findings in this study suggest that Rtt106 and SWI/SNF are general regulators of the PDR network genes and confer drug resistance in S. cerevisiae, and their roles are largely conserved in the pathogenic fungus C. glabrata.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe experiments for confirming the expression of a series of epitope-tagged Pdr3 (Supplementary Fig. 3b, c) were performed once with at least two different isolates which showed similar results.
“The experiments for confirming the expression of a series of epitope-tagged Pdr3 (Supplementary Fig. 3b, c) were performed once with at least two different isolates which showed similar results.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
InterpretationreasoningRtt106 and some SWI/SNF subunits are fungal-specific, and these factors offer attractive therapeutic targets to combat antifungal drug resistance in C. glabrata and potentially other Candida species.
“Since Rtt106 and some SWI/SNF subunits are fungal-specific, these factors offer attractive therapeutic targets to combat antifungal drug resistance in C. glabrata and potentially other Candida species.”
Quote in the paperSubstantial claim- Rests on an assumption: Rtt106 and some SWI/SNF subunits are fungal-specific.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataFor Northern blot and GST pull-down analyses and testing protein level of Pdr5 (Fig. 4b), each experiment was repeated three times independently with similar results, and one representative data of the replicates are presented.
“For Northern blot and GST pull-down analyses and testing protein level of Pdr5 (Fig. 4b), each experiment was repeated three times independently with similar results, and one representative data of the replicates are presented.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductreasoningMass spectrometry analysis of isolated minichromosome was performed once; proteins quantified at least 5 ratio counts were presented, allowing reliable quantification of proteins in the sample analysed.
“Mass spectrometry analysis of isolated minichromosome was performed once and therefore proteins quantified at least 5 ratio counts were presented, allowing reliable quantification of proteins in the sample analysed.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn human, histone chaperones HIRA and ASF1a localise at active promoters where BRG1, a human SWI/SNF complex subunit, also localises.
“In human, histone chaperones HIRA and ASF1a localise at active promoters where BRG1, a human SWI/SNF complex subunit, also localises52.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [52] Pchelintsev, N. A. et al. Placing the HIRA histone chaperone complex in the chromatin landscape. Cell Rep. 3, 1012–1019 (2013). source
Not checked in the free run.
May combine two claims.
Interpretationown dataRtt106 drives Pdr3-mediated expression of PDR5 and confers resistance to azole antifungals in S. cerevisiae.
“In S. cerevisiae, Rtt106 is recruited to the promoter of the multidrug transporter gene PDR5 exclusively through the transcription factor Pdr3, which drives Pdr3-mediated expression of PDR5, and confers resistance to azole antifungals.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataRtt106 and SWI/SNF upregulate PDR network gene expression and confer drug resistance in S. cerevisiae and C. glabrata.
“In this study, we found that Rtt106 and SWI/SNF upregulate PDR network gene expression and confer drug resistance in S. cerevisiae and C. glabrata.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationC. albicans SWI/SNF mediates overexpression of the drug efflux protein Mdr1 due to GOF mutations in the transcription factor Mrr1, thus conferring fluconazole resistance.
“C. albicans SWI/SNF mediates overexpression of the drug efflux protein Mdr1 due to GOF mutations in the transcription factor Mrr1, thus conferring fluconazole resistance55.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [55] Liu, Z. & Myers, L. C. Candida albicans Swi/Snf and mediator complexes differentially regulate Mrr1-induced MDR1 expression and fluconazole resistance. Antimicrob. Agents Chemother. 61, e01344–e01317 (2017).
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenA strict target FDR of 0.01 was used for the decoy database search in mass spectrometry data analysis.
“A strict target FDR of 0.01 for the decoy database search was used.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationHIRA mediates the replacement of canonical H3 with the H3.3 variant at promoters.
“HIRA mediates the replacement of canonical H3 with the H3.3 variant at promoters52, and continuous H3.3 exchange has been proposed to keep these sites transiently exposed, allowing transcription factors to access their binding sites53.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [52] Pchelintsev, N. A. et al. Placing the HIRA histone chaperone complex in the chromatin landscape. Cell Rep. 3, 1012–1019 (2013). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationGOF mutations in CgPdr1 make it hyperactive, resulting in high multidrug transporter expression and thus driving antifungal resistance in clinical isolates of C. glabrata.
“GOF mutations in CgPdr1 make it hyperactive, resulting in high multidrug transporter expression and thus driving antifungal resistance in clinical isolates of C. glabrata9,54.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [9] Ferrari, S. et al. Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence. PLoS Pathog. 5, e1000268 (2009). source
Not checked in the free run.
- cites [54] Tsai, H. F., Krol, A. A., Sarti, K. E. & Bennett, J. E. Candida glabrata PDR1, a transcriptional regulator of a pleiotropic drug resistance network, mediates azole resistance in clinical isolates and petite mutants. Antimicrob. Agents Chemother. 50, 1384–1392 (2006). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenERCC spike-in controls were added to the RNA samples to be used as internal controls.
“ERCC (External RNA Controls Consortium) spike-in controls were added to the RNA samples to be used as internal controls.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationHistone chaperone Asf1 mediates nucleosome disassembly from the PHO5 promoter for its activation in yeast.
“It has been reported that histone chaperone Asf1 mediates nucleosome disassembly from the PHO5 promoter for its activation in yeast22,23.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [22] Adkins, M. W., Howar, S. R. & Tyler, J. K. Chromatin disassembly mediated by the histone chaperone Asf1 is essential for transcriptional activation of the yeast PHO5 and PHO8 genes. Mol. Cell 14, 657–666 (2004). source
Not checked in the free run.
- cites [23] Korber, P. et al. The histone chaperone Asf1 increases the rate of histone eviction at the yeast PHO5 and PHO8 promoters. J. Biol. Chem. 281, 5539–5545 (2006). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationRapid histone turnover occurs at other sites where Rtt106 is enriched, including tRNA and snoRNA.
“Interestingly, in S. cerevisiae rapid histone turnover also has been shown to occur at other sites where Rtt106 is enriched, including tRNA and snoRNA51 (Fig. 2e and Supplementary Fig. 1d).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [51] Dion, M. F. et al. Dynamics of replication-independent histone turnover in budding yeast. Science 315, 1405–1408 (2007). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationC. glabrata has a single PDRE-binding transcription factor CgPdr1 that shares homology almost equally with S. cerevisiae Pdr1 and Pdr3 and possesses a blend of their properties.
“A major difference between C. glabrata and S. cerevisiae in the PDR network regulation is that C. glabrata has the single PDRE-binding transcription factor called CgPdr1 which shares homology almost equally with the S. cerevisiae Pdr1 and Pdr3 proteins, and possesses a blend of the properties of each50.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [50] Paul, S., Schmidt, J. A. & Moye-Rowley, W. S. Regulation of the CgPdr1 transcription factor from the pathogen Candida glabrata. Eukaryot. Cell 10, 187–197 (2011). source
Not checked in the free run.
May combine two claims.
Interpretationown dataCgRtt106 and CgSWI/SNF drive the expression of the PDR network genes in C. glabrata, with contributions limited to drug-induced expression.
“These results suggest that CgRtt106 and CgSWI/SNF drive the expression of the PDR network genes in C. glabrata, although their contributions appear limited to drug-induced expression.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataCgRtt106 and CgSWI/SNF upregulate the expression of multidrug transporter genes and confer antifungal resistance in C. glabrata.
“Taken together, these results demonstrate that CgRtt106 and CgSWI/SNF upregulate the expression of multidrug transporter genes and confer antifungal resistance in C. glabrata.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe inserted sequences were confirmed by sequencing.
“The inserted sequences were confirmed by sequencing.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataMinichromosome isolation and purification of the SWI/SNF complex followed by SYPRO Ruby staining (Supplementary Fig. 6a, b) were repeated three times independently with similar results; data from one representative experiment are shown.
“Minichromosome isolation and purification of the SWI/SNF complex followed by SYPRO Ruby staining (Supplementary Fig. 6a, b) were repeated three times independently with similar results; data from one representative experiment are shown.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningDuring logarithmic growth, Rtt106 and SWI/SNF bind to promoters of the PDR network genes mainly through Pdr3 and cooperatively drive Pdr3-dependent expression.
“Taken together, we propose that during logarithmic growth Rtt106 and SWI/SNF bind to promoters of the PDR network genes mainly through Pdr3, and cooperatively drive Pdr3-dependent expression; while in response to ketoconazole SWI/SNF mediates Pdr1-dependent-drug-induced expression of the PDR network genes in S. cerevisiae (Fig. 6h).”
Quote in the paperSubstantial claim
The paper relies on this without support.
Ketoconazole stimulates only Pdr1 in the condition tested.
“which stimulates only Pdr1 in the condition tested”
The paper relies on this without support.
Rtt106 and some SWI/SNF subunits are fungal-specific.
“Since Rtt106 and some SWI/SNF subunits are fungal-specific”
The paper relies on this without support.
The TSS-associated +1 nucleosome is critical for transcription initiation.
“which is critical for transcription initiation”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Rtt106 and some SWI/SNF subunits may serve as promising therapeutic targets to overcome antifungal resistance in C. glabrata.
“Notably, Rtt106 and some SWI/SNF subunits are fungal-specific and thus may serve as promising therapeutic targets to overcome antifungal resistance in this important pathogen99.”
From Molecular mechanisms governing antifungal drug resistance (2023) · cites this paper as [99]
In C. glabrata, the SWI/SNF complex and the histone chaperone Rtt106 mediate azole resistance by driving the expression of multidrug transporter genes including CDR1.
“In C. glabrata, the SWI/SNF complex, along with the histone chaperone Rtt106, mediate azole resistance by driving the expression of the multidrug transporter genes, including CDR199.”
From Molecular mechanisms governing antifungal drug resistance (2023) · cites this paper as [99]
Rtt106 and some SWI/SNF subunits are fungal-specific.
“Notably, Rtt106 and some SWI/SNF subunits are fungal-specific and thus may serve as promising therapeutic targets to overcome antifungal resistance in this important pathogen99.”
From Molecular mechanisms governing antifungal drug resistance (2023) · cites this paper as [99]
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041 · see citing works
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364 · see citing works
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219 · see citing works
HISAT: a fast spliced aligner with low memory requirements
Kim, D., Langmead, B., & Salzberg, S. L. (2015) · Nature Methods · doi:10.1038/nmeth.3317 · Cited by 24,112 · see citing works
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855 · see citing works
Longtine, M. S., Mckenzie, A., DeMarini, D. J., Shah, N. G., Wach, A., Brachat, A., Philippsen, P., & Pringle, J. R. (1998) · Yeast · doi:10.1002/(sici)1097-0061(199807)14:10 · Cited by 5,367 · see citing works
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284 · see citing works
Pappas, P. G., Lionakis, M. S., Arendrup, M. C., Ostrosky-Zeichner, L., & Kullberg, B. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.26 · Cited by 1,636 · see citing works
Histone exchange, chromatin structure and the regulation of transcription
Venkatesh, S., & Workman, J. L. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3941 · Cited by 940 · see citing works
S-phase checkpoint proteins Tof1 and Mrc1 form a stable replication-pausing complex
Katou, Y., Kanoh, Y., Bando, M., Noguchi, H., Tanaka, H., Ashikari, T., Sugimoto, K., & Shirahige, K. (2003) · Nature · doi:10.1038/nature01900 · Cited by 649 · see citing works
Dynamics of Replication-Independent Histone Turnover in Budding Yeast
Dion, M. F., Kaplan, T., Kim, M., Buratowski, S., Friedman, N., & Rando, O. J. (2007) · Science · doi:10.1126/science.1134053 · Cited by 556 · see citing works
Genome-wide structure and organization of eukaryotic pre-initiation complexes
Rhee, H. S., & Pugh, B. F. (2012) · Nature · doi:10.1038/nature10799 · Cited by 496 · see citing works
Understanding nucleosome dynamics and their links to gene expression and DNA replication
Lai, W. K. M., & Pugh, B. F. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.47 · Cited by 495 · see citing works
Antifungal resistance: current trends and future strategies to combat
Wiederhold, N. P. (2017) · Infection and Drug Resistance · doi:10.2147/idr.s124918 · Cited by 477 · see citing works
Balzi, E., Wang, M., Leterme, S., Van Dyck, L., & Goffeau, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42155-7 · Cited by 447 · see citing works
Acetylation of Histone H3 Lysine 56 Regulates Replication-Coupled Nucleosome Assembly
Li, Q., Zhou, H., Wurtele, H., Davies, B., Horazdovsky, B., Verreault, A., & Zhang, Z. (2008) · Cell · doi:10.1016/j.cell.2008.06.018 · Cited by 447 · see citing works
Whole-genome expression analysis of <i>snf/swi</i> mutants of <i>Saccharomyces</i> <i>cerevisiae</i>
Sudarsanam, P., Iyer, V. R., Brown, P. O., & Winston, F. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3364 · Cited by 389 · see citing works
A nuclear receptor-like pathway regulating multidrug resistance in fungi
Thakur, J. K., Arthanari, H., Yang, F., Pan, S.-J., Fan, X., Breger, J., Frueh, D. P., Gulshan, K., Li, D. K., Mylonakis, E., et al. (2008) · Nature · doi:10.1038/nature06836 · Cited by 343 · see citing works
Rufiange, A., Jacques, P.-É., Bhat, W., Robert, F., & Nourani, A. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.07.011 · Cited by 313 · see citing works
Ferrari, S., Ischer, F., Calabrese, D., Posteraro, B., Sanguinetti, M., Fadda, G., Rohde, B., Bauser, C., Bader, O., & Sanglard, D. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000268 · Cited by 295 · see citing works
Adkins, M. W., Howar, S. R., & Tyler, J. K. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.05.016 · Cited by 294 · see citing works
New vectors for simple and streamlined CRISPR-Cas9 genome editing in Saccharomyces cerevisiae
Laughery, M. F., Hunter, T., Brown, A., Hoopes, J. I., Ostbye, T., Shumaker, T., & Wyrick, J. J. (2015) · Yeast · doi:10.1002/yea.3098 · Cited by 292 · see citing works
Yeast multidrug resistance: The PDR network
Balzi, E., & Goffeau, A. (1995) · Journal of Bioenergetics and Biomembranes · doi:10.1007/bf02110333 · Cited by 279 · see citing works
Kemmeren, P., Sameith, K., van de Pasch, L. A. L., Benschop, J. J., Lenstra, T. L., Margaritis, T., O’Duibhir, E., Apweiler, E., van Wageningen, S., Ko, C. W., et al. (2014) · Cell · doi:10.1016/j.cell.2014.02.054 · Cited by 277 · see citing works
Recruitment of the SWI/SNF chromatin remodeling complex by transcriptional activators
Yudkovsky, N., Logie, C., Hahn, S., & Peterson, C. L. (1999) · Genes & Development · doi:10.1101/gad.13.18.2369 · Cited by 241 · see citing works
Tsai, H.-F., Krol, A. A., Sarti, K. E., & Bennett, J. E. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1384-1392.2006 · Cited by 237 · see citing works
Scholes, D. T., Banerjee, M., Bowen, B., & Curcio, M. J. (2001) · Genetics · doi:10.1093/genetics/159.4.1449 · Cited by 235 · see citing works
Transcriptional control of the yeast PDR5 gene by the PDR3 gene product.
Katzmann, D. J., Burnett, P. E., Golin, J. E., Mahé, Y., & Moye-Rowley, S. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4653 · Cited by 216 · see citing works
Dynamic changes in histone acetylation regulate origins of DNA replication
Unnikrishnan, A., Gafken, P. R., & Tsukiyama, T. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1780 · Cited by 196 · see citing works
Hallstrom, T. C., & Moye-Rowley, W. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007338200 · Cited by 194 · see citing works
Transcription Activator Interactions with Multiple SWI/SNF Subunits
Neely, K. E., Hassan, A. H., Brown, C. E., Howe, L., & Workman, J. L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.6.1615-1625.2002 · Cited by 183 · see citing works
Interaction of the yeast pleiotropic drug resistance genes PDR1 and PDR5
Meyers, S., Schauer, W., Balzi, E., Wagner, M., Goffeau, A., & Golin, J. (1992) · Current Genetics · doi:10.1007/bf00351651 · Cited by 156 · see citing works
Inhibiting fungal multidrug resistance by disrupting an activator–Mediator interaction
Nishikawa, J. L., Boeszoermenyi, A., Vale-Silva, L. A., Torelli, R., Posteraro, B., Sohn, Y.-J., Ji, F., Gelev, V., Sanglard, D., Sanguinetti, M., et al. (2016) · Nature · doi:10.1038/nature16963 · Cited by 146 · see citing works
Placing the HIRA Histone Chaperone Complex in the Chromatin Landscape
Pchelintsev, N. A., McBryan, T., Rai, T. S., van Tuyn, J., Ray-Gallet, D., Almouzni, G., & Adams, P. D. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.03.026 · Cited by 143 · see citing works
Delahodde, A., Delaveau, T., & Jacq, C. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4043 · Cited by 142 · see citing works
Shivaswamy, S., & Iyer, V. R. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01659-07 · Cited by 139 · see citing works
Multidrug resistance in fungi: regulation of transporter-encoding gene expression
Paul, S., & Moye-Rowley, W. S. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00143 · Cited by 137 · see citing works
Quality control of transcription start site selection by nonsense-mediated-mRNA decay
Malabat, C., Feuerbach, F., Ma, L., Saveanu, C., & Jacquier, A. (2015) · eLife · doi:10.7554/elife.06722 · Cited by 134 · see citing works
Kubik, S., O’Duibhir, E., de Jonge, W. J., Mattarocci, S., Albert, B., Falcone, J.-L., Bruzzone, M. J., Holstege, F. C. P., & Shore, D. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.05.030 · Cited by 133 · see citing works
Rtt106p is a histone chaperone involved in heterochromatin-mediated silencing
Huang, S., Zhou, H., Katzmann, D., Hochstrasser, M., Atanasova, E., & Zhang, Z. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506176102 · Cited by 130 · see citing works
Structural basis for recognition of H3K56-acetylated histone H3–H4 by the chaperone Rtt106
Su, D., Hu, Q., Li, Q., Thompson, J. R., Cui, G., Fazly, A., Davies, B. A., Botuyan, M. V., Zhang, Z., & Mer, G. (2012) · Nature · doi:10.1038/nature10861 · Cited by 128 · see citing works
Opposing chromatin remodelers control transcription initiation frequency and start site selection
Kubik, S., Bruzzone, M. J., Challal, D., Dreos, R., Mattarocci, S., Bucher, P., Libri, D., & Shore, D. (2019) · Nature Structural & Molecular Biology · doi:10.1038/s41594-019-0273-3 · Cited by 126 · see citing works
Mamnun, Y. M., Pandjaitan, R., Mahé, Y., Delahodde, A., & Kuchler, K. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03262.x · Cited by 125 · see citing works
van Bakel, H., Tsui, K., Gebbia, M., Mnaimneh, S., Hughes, T. R., & Nislow, C. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003479 · Cited by 124 · see citing works
Fungal ATP-Binding Cassette (ABC) Transporters in Drug Resistance & Detoxification
Sipos, G., & Kuchler, K. (2006) · Current Drug Targets · doi:10.2174/138945006776359403 · Cited by 123 · see citing works
Mahé, Y., Parle‐McDermott, A., Nourani, A., Delahodde, A., Lamprecht, A., & Kuchler, K. (1996) · Molecular Microbiology · doi:10.1111/j.1365-2958.1996.tb02493.x · Cited by 117 · see citing works
Regulation of Histone Gene Expression in Budding Yeast
Eriksson, P. R., Ganguli, D., Nagarajavel, V, & Clark, D. J. (2012) · Genetics · doi:10.1534/genetics.112.140145 · Cited by 114 · see citing works
Fillingham, J., Kainth, P., Lambert, J.-P., van Bakel, H., Tsui, K., Peña-Castillo, L., Nislow, C., Figeys, D., Hughes, T. R., Greenblatt, J., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.06.023 · Cited by 108 · see citing works
Korber, P., Barbaric, S., Luckenbach, T., Schmid, A., Schermer, U. J., Blaschke, D., & Hörz, W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513340200 · Cited by 106 · see citing works
A Role for Transcriptional Repressors in Targeting the Yeast Swi/Snf Complex
Dimova, D., Nackerdien, Z., Furgeson, S., Eguchi, S., & Osley, M. A. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80189-6 · Cited by 105 · see citing works
Wolfger, H., Mahé, Y., Parle-McDermott, A., Delahodde, A., & Kuchler, K. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01382-3 · Cited by 97 · see citing works
Separation of long RNA by agarose–formaldehyde gel electrophoresis
Mansour, F. H., & Pestov, D. G. (2013) · Analytical Biochemistry · doi:10.1016/j.ab.2013.06.008 · Cited by 89 · see citing works
Regulation of the CgPdr1 Transcription Factor from the Pathogen Candida glabrata
Paul, S., Schmidt, J. A., & Moye-Rowley, W. S. (2011) · Eukaryotic Cell · doi:10.1128/ec.00277-10 · Cited by 78 · see citing works
Imbeault, D., Gamar, L., Rufiange, A., Paquet, E., & Nourani, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800147200 · Cited by 66 · see citing works
Kubota, T., Hiraga, S., Yamada, K., Lamond, A. I., & Donaldson, A. D. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.005561 · Cited by 63 · see citing works
Self-citationGolin, J., & Ambudkar, S. V. (2015) · Biochemical Journal · doi:10.1042/bj20150042 · Cited by 63 · see citing works
Cankorur‐Cetinkaya, A., Eke, E. D., Eraslan, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038351 · Cited by 61 · see citing works
Liu, Z., & Myers, L. C. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01344-17 · Cited by 51 · see citing works
Transcriptional Control of the Yeast PDR5 Gene by the PDR3 Gene Product
Katzmann, D. J., Burnett, P. E., Golin, J. E., Mahé, Y., & Moye-Rowley, S. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4653-4661.1994 · Cited by 51 · see citing works
Shahi, P., Gulshan, K., Näär, A. M., & Moye-Rowley, W. S. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-10-0899 · Cited by 49 · see citing works
Two surfaces on the histone chaperone Rtt106 mediate histone binding, replication, and silencing
Zunder, R. M., Antczak, A. J., Berger, J. M., & Rine, J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119095109 · Cited by 48 · see citing works
Mao, X., Cao, F., Nie, X., Liu, H., & Chen, J. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.04.009 · Cited by 45 · see citing works
Swi/Snf dynamics on stress-responsive genes is governed by competitive bromodomain interactions
Dutta, A., Gogol, M., Kim, J.-H., Smolle, M., Venkatesh, S., Gilmore, J., Florens, L., Washburn, M. P., & Workman, J. L. (2014) · Genes & Development · doi:10.1101/gad.243584.114 · Cited by 45 · see citing works
Causey, D. R., Kim, J., Stead, D., Martín, S., Devlin, R. H., & Macqueen, D. J. (2018) · Journal of Proteomics · doi:10.1016/j.jprot.2018.08.013 · Cited by 45 · see citing works
Kurat, C. F., Lambert, J.-P., van Dyk, D., Tsui, K., van Bakel, H., Kaluarachchi, S., Friesen, H., Kainth, P., Nislow, C., Figeys, D., et al. (2011) · Genes & Development · doi:10.1101/gad.173427.111 · Cited by 41 · see citing works
Gkikopoulos, T., Havas, K. M., Dewar, H., & Owen-Hughes, T. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00400-09 · Cited by 33 · see citing works
Jenull, S., Tscherner, M., Gulati, M., Nobile, C. J., Chauhan, N., & Kuchler, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-08239-9 · Cited by 28 · see citing works
Structure of the yeast Swi/Snf complex in a nucleosome free state
Wang, C., Guo, Z., Zhan, X., Yang, F., Wu, M., & Zhang, X. (2020) · Nature Communications · doi:10.1038/s41467-020-17229-x · Cited by 25 · see citing works
Quantitative proteomic analysis of yeast DNA replication proteins
Kubota, T., Stead, D., Hiraga, S., ten Have, S., & Donaldson, A. D. (2012) · Methods · doi:10.1016/j.ymeth.2012.03.012 · Cited by 23 · see citing works
Self-citationRegulation of Mec1 kinase activity by the SWI/SNF chromatin remodeling complexPreprint
Kapoor, P., Bao, Y., Xiao, J., Luo, J., Shen, J., Persinger, J., Peng, G., Ranish, J. A., Bartholomew, B., & Shen, X. (2015) · Genes & Development · doi:10.1101/gad.257626.114 · Cited by 23 · see citing works
Zunder, R. M., & Rine, J. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00871-12 · Cited by 22 · see citing works
Ferreira, M. E., Flaherty, K., & Prochasson, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021113 · Cited by 21 · see citing works
Maintenance of Nucleosomal Balance in<i>cis</i>by Conserved AAA-ATPase Yta7
Lombardi, L. M., Davis, M. D., & Rine, J. (2015) · Genetics · doi:10.1534/genetics.114.168039 · Cited by 16 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Molecular mechanisms governing antifungal drug resistance
Lee, Y., Robbins, N., & Cowen, L. E. (2023) · npj Antimicrobials and Resistance · doi:10.1038/s44259-023-00007-2 · Cited by 304 · see citing works
- Authors
- Nikolov, V. N., Malavia, D., & Kubota, T.
- Affiliations
- University of Aberdeen (GB)
- Corresponding author
- Kubota, Takashi
- Venue
- Nature Communications
- Published
- 2022-04-12
- Volume
- 13
- Issue
- 1
- Pages
- 1968-1968
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC9005695
- OpenAlex
- W4223601276
- Semantic Scholar
- 75c5ac0e730e0ca6b6cb24b635efaeac3164c056
- Cited by
- 16
- References
- 73
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 7 · 2023: 2 · 2022: 1
- FWCI
- 1.06
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Aberdeen University Research Archive (Aberdeen University) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Wellcome Trust (097377/Z/11/Z)
- RCUK | Medical Research Council (L019698/1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- histone chaperone, PDR1, antifungal resistance, antifungal drug response, Candida glabrata, Saccharomyces cerevisiae, gene expression regulation, transcriptional regulation, therapeutic target
- MeSH terms
- Antifungal Agents, Drug Resistance, Saccharomyces cerevisiae, Transcription Factors, Molecular Chaperones, Saccharomyces cerevisiae Proteins, Histone Chaperones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review